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This collection of publications serves as the introduction to a new approach in biol-
ogy and pharmacology: exploiting the peculiar properties of supramolecular sys-
tems, particularly ribbonlike micellar structures which constitute an entirely new 
category of protein ligands. The novelty of the problem is reflected by the specific 
character of such ligands but also by the way in which they bind to proteins – a 
mechanism unlike “classic” ligand binding. Among described problems of impor-
tance are enhancement of immune complexation by supramolecular ligands and 
their possible use as carriers for drugs. Many of those supramolecular compounds, 
including Congo red and Evans blue, have long been used as dyes and amyloid 
markers; however, we are only now beginning to understand their specific chemistry 
and interaction with proteins.
The micellar structure of supramolecular ligands enables intercalation of foreign 
particles, including drugs. This phenomenon is particularly interesting given the 
ligands’ known affinity for antibodies – but only those engaged in immune com-
plexes. Another important advantage is the strengthening of antigen-antibody inter-
actions brought about by complexation of a supramolecular ligand. It therefore 
seems likely that supramolecular ligands will find use in immunotargeting.
Intercalation of customized complexones enables supramolecular ligands to 
inject metal ions into proteins – in order to provide contrast for EM imaging but also 
for therapeutic purposes.
The analysis of the complexation behavior of supramolecular ligands casts a new 
light on the phenomenon of amyloidogenesis. We can expect that further research 
into supramolecular systems will lead to a wider range of practical applications. The 
authors are predominantly biochemists involved in supramolecular compound 
application in biology and medicine. The ideas and results presented shall be of 
interest for researchers looking for new materials and methods in antibacterial 
therapy.
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Chapter 1
Supramolecular Systems as Protein Ligands
Joanna Rybarska, Barbara Piekarska, Barbara Stopa, Grzegorz Zemanek, 
Leszek Konieczny, and Irena Roterman
Abstract The standard substrate complexation mechanism engages natural bind-
ing sites. In contrast, supramolecular structures may form complexes with proteins 
by penetrating in regions which are either naturally unstable or become temporarily 
accessible due to structural rearrangements related to the protein’s function. This 
may result in enhancement of irreversible processes (e.g. immune complexation or 
complement activation) or inhibition of reversible processes (e.g. enzymatic cataly-
sis). Only ribbon-like supramolecular structures may form complexes with proteins. 
Having anchored itself inside the protein, the supramolecular ligand is protected 
against environmental factors such as changes in pH. This type of interaction repre-
sents a unique, nonstandard phenomenon in the context of proteomics.
Keywords Protein dynamics and Congo red binding • Ribbon-like supramolecular 
micelles • Congo red as supramolecular dye • Self-assembled molecules form a unit 
protein ligand • Unity of self-assembled molecules • Congo red penetration to pro-
tein interior • Congo red complexation properties • Protection of bound Congo red 
by proteins
1.1  Mechanism of Complexation
Biological function is a critical aspect in proteomics, and is often defined as the 
capability to interact with specific ligands and form complexes. Protein ligands tend 
to be either small molecules or small fragments of larger systems. They bind to the 
target protein in a specific area called the active site (or active group). Typically, the 
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active site is a pocket where the ligand may directly contact the nonpolar interior of 
the protein – an environment which excludes water. The result is a stable complex 
and the ability to carry out reactions which would not be possible in an aqueous 
solution.
Proteins are generally incapable of interaction in areas other than their active 
sites, since tight packing of polypeptide chains prevents penetration of random 
ligands. Nevertheless, the protein is not a monolith: its dynamic nature means that 
under certain conditions the packing of polypeptide chains may undergo relaxation, 
enabling small molecules to penetrate protein interior [1–6]. Those ligands cannot 
form stable bonds due to low binding energy in an area otherwise unprepared for 
specific interaction with such compounds – to put it simply, a rigid molecule is not 
likely to exhibit good alignment with the conformation of a folded polypeptide 
chain. The high mobility of small ligands also discourages strong interactions.
In spite of the above, some supramolecular associations of organic compounds 
are able to penetrate and anchor themselves inside proteins. This unique property 
emerges as a result of association (or self-association) of individual molecules [7–
12], and is linked to the flexible structure and large interaction surfaces exposed by 
supramolecular ligands.
The presence of noncovalent bonds in supramolecular structures allows their 
components to shift with respect to one another, resulting in an adaptive ligand 
which has greater conformational alignment capabilities than polymers or small 
organic molecules.
Ongoing progress in supramolecular chemistry opens new research avenues and 
highlights new uses for associative structures [13–19]. Currently, research effort 
focuses primarily on technological improvements, including novel sieves, adsorp-
tion systems or tools which exploit various mechanical effects. The goal of such 
initiatives is to synthesize suitable monomers (or polymeric structures), which can 
then associate with one another according to a predefined blueprint, producing com-
plex supramolecular units (Fig. 1.1). Relatively little work has been done in the area 
of identifying biological applications of such structures.
Noncovalent association as a means of generating complex structures is a ubiq-
uitous phenomenon in nature. One classic example is the formation of molecular 
membranes, where a counterbalance of positive and negative charges in the polar 
component of each monomer eliminates electrostatic repulsion and allows mole-
cules to align side by side in water, forming sheets. Another example involves 
microtubules which consist of self-associating proteins (Fig. 1.2).
Not all associative organic structures are capable of attaching to proteins. In fact, 
only one specific type of supramolecular structure can form complexes with suffi-
cient stability to contemplate practical applications: systems which adopt ribbon- 
like micellar conformations (Fig. 1.3).
Ribbon-like micelles are the result of association of flat, polyaromatic, elon-
gated, symmetrical molecules with polar groups at either end. Examples include CR 
and EB [20, 21]. Ligands consisting of several such molecules may penetrate into 
the protein interior by exploiting local instabilities or gaps created through acciden-
tal displacement of polypeptide loops. The ligand typically anchors itself between 
J. Rybarska et al.
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beta folds or random coils, since these two structural forms of polypeptide chain 
expose suitably large contact areas. Figure  1.4 illustrates the complexation 
process.
Owing to its structural flexibility, the supramolecular ligand may interact with 
proteins as the specific component – although its presence may also alter the target 
protein due to the large interaction area and strength of binding. Both structures 
adapt finally to each other, producing a stable bond [22].
Fig. 1.1 Formation of one-, two- and three-dimensional associations of monomers – schematic 
presentation
Fig. 1.2 Schematic depiction of cell membrane. Fencepost-like arrangement of phospholipid mol-
ecules enabled to close contact owing to charge neutrality. Inset: directed association of protein 
molecules – formation of microtubules
1 Supramolecular Systems as Protein Ligands
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The large volume of supramolecular ligands undoubtedly hampers penetration. 
Consequently, supramolecular ligands prefer interaction with inherently unstable 
proteins – such as partly unfolded proteins and amyloids [23–34]. In some cases, 
however, even a tightly packed protein may  – when binding its natural target 
ligand – undergo sufficient structural rearrangement to permit penetration of addi-
tional large supramolecular ligands penetrating outside of the primary binding site. 
This type of interaction, while temporary, often drastically modifies the function of 
the protein [35, 36].
Asymmetrical bipolar molecules which form supramolecular systems in water, 
such as detergents, form also complexes with proteins by penetrating into their 
hydrophobic areas; however, this mode of interaction differs from the one used by 
symmetrical molecules. With detergents penetration is diffuse and occurs wherever 
low polarity is present. This process produces major changes in the protein’s sec-
Fig. 1.3 Formation of supramolecular ribbon-like CR micelle. A - trans form of CR, B - cis form 
of CR
J. Rybarska et al.
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ondary conformation, ultimately leading to denaturation. The unfolded skeleton of 
the protein is then reused by the supramolecular ligand as a seed for micellar aggre-
gation. A typical example is the modification of polypeptide chains produced by 
SDS, commonly applied in polyacrylamide gel electrophoresis (Fig. 1.5) [37].
In contrast, flat, ribbon-like supramolecular ligands interact with proteins by 
“wedging” and produce no major changes in the protein’s distribution of hydropho-
bicity. Despite forming a complex with the ribbon-like ligand, the protein retains its 
native interaction capabilities. This effect is reinforced by the stability and cohesive 
nature of the ligand itself (caused by strong intermolecular association). If the target 
protein acquires the ability to bind a supramolecular structure as a result of interact-
ing with its natural ligand, then the presence of the supramolecular structure tends 
to stabilize the original protein/ligand complex. This occurs in the case of nonre-
versible interactions, such as between antigens and antibodies. On the other hand, 
supramolecular ligands are also able to inhibit the activity of enzymes by “freezing” 
them in their complex with the substrate. Such uncompetitive inhibition differs by a 
mechanism from that known as noncompetitive one. It indicates that ribbon-like 
supramolecular structures may also be of use in pharmacology as distinct inhibitors 
[38, 39] (Fig. 1.6).
Fig. 1.4 CR/polypeptide complexation principle. (A and B) Molecular model (90-degree rota-
tion). (C) Schematic view of CR (supramolecular) in complex with polylysine
1 Supramolecular Systems as Protein Ligands
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Uncompetitive inhibition is rarely encountered in nature as most inhibition pro-
cesses are either competitive or noncompetitive in nature. In this specific case the 
inhibitor does not attach itself to the enzyme but rather to the entire enzyme- substrate 
complex, stabilizing it and negating the reversibility of complexation (Fig. 1.7).
It appears however that in order to form stable complexes with proteins without 
degrading their structure, supramolecular ligands must exhibit a ribbon-like confor-
mation. It should also be noted that the distribution of polarity in a ribbon-like 
Fig. 1.5 Formation of rod-like structures of SDS: A - with protein backbone, B - without protein 
backbone
Fig. 1.6 Model view of enzyme inhibited by a supramolecular ligand (uncompetitive inhibition)
J. Rybarska et al.
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micelle approximates the properties of a beta fold, promoting formation of a stable 
complex.
A ribbon-like supramolecular structure may emerge only when the long axes of asso-
ciating molecules are well aligned with each other. This condition is met when the axial 
alignment of each unit molecule is determined by its structural elongation (Fig. 1.8).
Another very important property of ribbon-likesupramolecular ligands, promot-
ing complexation, is the exposure of a large hydrophobic surface. The rigid struc-
ture and symmetrical distribution of charges in individual molecules prevent 
Fig. 1.7 Mathematical 
formulation of 
uncompetitive inhibition
Fig. 1.8 Elongated association area of symmetric self-assembling molecules, necessary for for-
mation of ribbon-like supramolecular structures
1 Supramolecular Systems as Protein Ligands
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internalization of nonpolar fragments inside the micelle (which occurs in deter-
gents). Such exposure of hydrophobicity on the ligand surface greatly enhances its 
complexation capabilities, and does so in a specific way: while promoting adhesion, 
it does not enable the ligand to independently penetrate into the protein – again, in 
contrast to detergents (Fig. 1.9).
Binding CR increases the protein’s polarity, especially in light of the fact that, 
once anchored, a supramolecular ligand may sometimes propagate beyond the pro-
tein and attract additional dye molecules in its environment. As a result, a thermally 
aggregated protein (such as immunoglobulin G) may persist in solution, surrounded 
by free dye (Fig. 1.10) [40]. This has been proven through chromatographic separa-
tion (on a thin layer of Sephadex G200) of thermally aggregated immunoglobulin G 
solubilized in complex with the dye. Under EM imaging this heavy fraction appears 
as a cloud of dye particles with suspended thermally denatured immunoglobulin G, 
rendered soluble via complexation of CR.
Fig. 1.9 Exposure of 
non-polar fragments in a 
ribbon-like micelle 
composed of self- 
assembled symmetric 
molecules (arrow)
Fig. 1.10 Clouds of CR 
with solubilized, heat- 
aggregated IgG molecules 
(high molecular weight 
fraction of CR and 
heat-aggregated IgG 
complex extracted from 
molecular sieve 
chromatography – 
Sephadex G200). EM 
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Further adsorption of CR on Sephadex along the column eventually results in 
precipitation of insufficiently protected immunoglobulin molecules. To enhance the 
contrast of CR under EM we have added silver ions (AgNO3), which form weak 
complexes with the dye but remain in solution along the short Sephadex filtration 
path.
1.2  Structural Adaptability of Molecules Forming 
Supramolecular Structures
Taken together, the presented characteristics – flat ribbon-like structure, flexibility, 
large interaction surface and exposure of hydrophobicity – promote interaction and 
formation of stable complexes with proteins penetrating to areas which are not bio-
logically configured for binding ligands. Another important factor which enhances 
the adaptability of the CR micelle is some kind of plasticity of individual molecules, 
permitting rotation about the central bond between aromatic rings, as well as about 
both lateral azo bonds.
Substituents in conjugated chemical compounds – including polyaromatic com-
pounds – act upon one another. This affects their properties as well as the properties 
of the entire molecule. The location of such substituents in the molecule is also 
important. Figure 1.11 presents potentiometric titration of CR and its derivative – 
4,4′-bis(1-amino-6-sulphonaphtyl-4-azo-biphenyl Direct Red II), with an identical 
formula but a different arrangement of polar groups, resulting in a different value of 
amino groups – pK [41, 42].
Fig. 1.11 Altered placement of substituents in CR derivative resulting in altered pK of the amino 
group. Potentiometric titration. Control NaCl - red line
1 Supramolecular Systems as Protein Ligands
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The rotational freedom associated with azo bonds is strongly dependent on the 
substituents on aromatic rings; especially those located in close proximity to each 
azo bond and affecting its polarization, which may either enhance or stifle rotational 
freedom (Fig.  1.12). To illustrate this fact, we compare CR with its analogue  – 
4,4′bis(1-amino-5-sulfonaphthyl-2-azo)biphenyl  – where greater separation 
between the azo bonds and the sulfonic groups significantly reduces complexation 
capabilities (Fig. 1.12 – A and B). In contrast, fixation of the central bond in the 
fluorene derivative (with the accompanying planarization of the molecule) promotes 
Fig. 1.12 Structural modification of CR molecule – formulas 1, 2, 3, 6 and EB – formulas 4, 5 and 
their effect on supramolecular binding to proteins: black bars – heat-aggregated IgG (less restric-
tive binding). Presented value – the number of bound molecules (molar ratio); gray bars – native 
IgG (more restrictive binding – antibodies agglutinating red cells). Presented value – enhancement 
of agglutination
J. Rybarska et al.
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self-association, but reduces the system’s flexibility. This is evidenced by more 
dense clustering and binding with thermally aggregated immunoglobulin G (where 
the ligand binding tolerance is high), but reduced capabilities for active site com-
plexation in antibodies and the correspondingly weaker enhancement of agglutina-
tion (Fig.  1.12  – 1 and 3). Further analysis of this phenomenon is possible by 
measuring enhancement of agglutination in the SRBC-anti-SRBC model caused by 
complexation of CR. The observed effect is caused by greater involvement of serum 
polyclonal antibodies in agglutination resulting from complexation of the supramo-
lecular ligand. Complexation capabilities are finally measured by: A – counting the 
number of dye molecules attached to a single thermally aggregated immunoglobu-
lin G molecule where more than one anchoring site is present; B – assessing the 
degree to which agglutination is enhanced in the SRBC-anti-SRBC model, under 
the assumption that the supramolecular ligand increases antibody binding strength 
and its capacity for immunological complexation. Since such effects require precise 
alignment of the ligand with the domain V binding site, they provide a measure of 
the ligand’s flexibility. This property can be directly quantified by measuring the 
readiness for immunological complexation of weak antibodies found in the poly-
clonal anti-SRBC serum, and the corresponding increase in agglutination.
The relation between degrees of rotational freedom, charge distribution and pro-
tein binding capabilities is also evident when comparing EB with Trypan blue (TB). 
Both dyes differ only with respect to the location of sulfonic groups. In Trypan blue 
this location is disadvantageous due to its proximity to both the azo bond and the 
central nonpolar region of the molecule (Fig. 1.12 – 4 and 5).
The need for a planar ribbon-like micelle becomes clear when we compare the 
complexation potency of CR with its derivative  – 
 1,4-bis(1-amino-4-sulphonaphtyl-2- azo)phenylene, in which the central biphenyl 
group has been replaced with a benzene ring, eliminating the need for specific spa-
tial orientation of the molecule’s long axis. The resulting micelle is not a ribbon 
even though its unit molecule closely resembles CR (Fig. 1.12 – 1 and 6). Instead, 
it produces a self-associating cylindrical structure, protecting nonpolar fragments 
from the external environment [43]. This effect also negates the protein complex-
ation capabilities of such a ligand (Fig. 1.13). Comparing the properties of both 
structurally similar dyes highlights the need for a ribbon-like conformation in 
supramolecular protein ligands.
Regarding protein structures, supramolecular ligands tend to preferentially form 
complexes with beta-structure and random coils of polypeptide chains. Elongated 
non-helical polypeptides represent a good match for the supramolecular ribbon 
itself, providing the ligand with a convenient anchoring point (Fig. 1.4).
Susceptibility for supramolecular ligand penetration varies from protein to pro-
tein. In addition to the degree of packing and the protein’s intrinsic stability it also 
depends – as remarked above – upon function-related conformational rearrange-
ment [35, 36, 38, 39].
The role of most proteins is to interact with specific targets. Such interaction 
affects the protein itself and often results in partial unfolding, which renders the 
protein susceptible to further penetration by a supramolecular ligand. This 
mechanism can be observed e.g. when analyzing the interaction of CR with 
1 Supramolecular Systems as Protein Ligands
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serum proteins. Note that the bloodstream typically contains acute phase pro-
teins, in complex with their respective ligands, and that such complexes are 
recognized and eliminated by macrophages and liver enzymes. We may there-
fore suspect that the capability for such selective elimination depends on func-
tion-related structural changes which occur in proteins introducing some local 
instability.
1.3  Specificity of Congo Red Complexation
The complexation capabilities of CR increase along with the dye’s concentration. 
This is related to increased probability of penetration into proteins as they undergo 
dynamic – and often temporary – structural changes. Furthermore, increased con-
centrations favor supramolecular association, resulting in longer micelles with more 
pronounced dipole characteristics. This effect can be revealed by measuring electro-
phoretic migration distance on the electrophoretic plate and present it as a function 
of dye concentration.
It seems that the properties of CR change qualitatively as its concentration 
increases, favoring protein complexation. At high concentrations the dye is even 
capable of penetrating into proteins at room temperature. The application of DMSO 
results in dissociation of the supramolecular structure; consequently, the electro-
phoretic migration speed again becomes independent of concentration (Fig. 1.14). 
Fig. 1.13 Self-assembly of molecules without imposed orientation (lack of elongated contact 
area), resulting in a cylindrical supramolecular structure with internalized non-polar fragments. 
Chemical formula of 1,4-bis(1-1amino-4-sulphonaphtyl-2-azo)phenylene
J. Rybarska et al.
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This proves that concentration determines the emergent, supramolecular properties 
of the dye – particularly its capability to form stable complexes with proteins.
In order to demonstrate this phenomenon, we have selected an immunoglobulin 
light chain which is relatively resistant to CR complexation in its native form. 
Heating the protein promotes complexation, but even at room temperature high con-
centrations result in two distinct complexes which migrate faster than the base pro-
tein – depending on the number of ligand molecules present in each complex. Here, 
complexation involves the variable V domain (Fig. 1.15) [44]. The “slow” migrating 
fraction carries ligands composed of four dye molecules, while in the “fast” fraction 
Fig. 1.14 Increased electrophoretic migration rate of CR corresponding to increased dye concen-
tration: A - 1,2,3,4,5, position 6 - bromophenol blue dye. B - concentration-independent migration 
in (DMSO – buffer mixture 1:2). Evidence of close CR self-assembly
Fig. 1.15 Two mutually- 
related complexes 
consisting of L-lambda 
chains and CR molecules, 
exhibiting different 
migration rates in 
electrophoresis (b and c) 
due to different well 
defined dye load. a – L 
chain, b – L chain 
complexed with 4 
molecular CR ligand, c – L 
chain complexed with 5–8 
molecular CR ligand, 
d – CR excess. 
Complexation induced by 
the step-wise increased 
concentration 
of CR - 1,2,3,4
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the size of the ligand varies between 5 and 8 molecules. Notably, the “fast” fraction 
produces a smeared electrophoretic band, showing that the ligand grows over time 
and that larger complexes are produced with greater difficulty than smaller ones.
The supramolecular ligand forms a tight bond with the protein and adapts itself 
to the new environment, as evidenced by a spectral shift towards greater wave-
lengths. This effect results from transitioning between water and an environment 
characterized by lower values of the dielectric constant (Fig. 1.16A) [45, 46].
Fig. 1.16 Spectral shift of CR in a low-polarity environment – A -1 – native concanavalin, 2 – 
heated concanavalin) and B - in alcohols (1- native concanavalin 2-methanol, 3-ethanol, 4- propanol) 
characterized by varying polarity
J. Rybarska et al.
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To further illustrate this effect, the spectrum of CR has been analyzed in the pres-
ence of alcohols containing increasingly larger nonpolar components: methanol, 
ethanol and propanol. The observed shift towards greater wavelengths confirms the 
stated hypothesis (Fig. 1.16B).
A complexed ligand bound in protein interior is protected against acidification 
by the protein. CR changes its color in an acidic environment due to change in the 
ionization of its amino groups. The color shift from red to blue is decisive and rapid 
in unbound dye, whereas dye-protein complexes retain their red coloration for some 
time (Fig. 1.17). Reduction by sodium dithionite deprives the dye of its color due to 
cleavage of azo bonds; however, protein complexation slows this reaction down 
significantly (Fig. 1.18).
Fig. 1.17 Dye protected against acidification by complexed protein measured by spectral change. 
1 – free dye, 2 – dye bound to protein (L chain IgG)
Fig. 1.18 Dye protected 
against reduction by 
complexed protein 
measured by spectral 
change. 1 – dye bound to 
protein, 2 – free dye
1 Supramolecular Systems as Protein Ligands
16
In summary, complexes consisting of supramolecular dyes and proteins appear 
to result from penetration of associated dye molecules into the target protein. The 
capability for such penetration depends on the cohesiveness of the dye micelle, as 
well as its shape.
In order for a supramolecular aggregation to function as a distinct protein ligand, 
the unit composed of self-assembled molecules must behave as a coherent whole. 
This depends on the self-association potency of the target substance – powerful self- 
association produces a ligand which readily interacts with proteins (Figs. 1.19 and 
1.20).
Another important property of supramolecular dyes is their capability to interca-
late foreign bodies (other than the self-associating unit molecules), resulting in 
ligands which can introduce foreign substances into proteins even when the protein 
does not, by itself, react with such substances [17, 47]. Rhodamine B – a basic dye 
which exhibits strong fluorescence and is therefore useful in imaging studies – may 
be intercalated into CR micelles and bound to proteins. Other potential intercalants 
Fig. 1.19 Self-assembly 
tendency correlated with 
corresponding different 
dye complexation activity 
measured as the yield of 
dye protein complexation 
at increasing temperature. 
Lines 1 and 2 according to 
chemical formulas 1 and 2 
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include heavy metal ions – such as in the case of TY, used as a carrier for silver ions 
to provide contrast for EM imaging of amyloid deposits [48]. The same mechanism 
may be used to introduce some alterations to properties of proteins.
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Chapter 2
Supramolecular Congo Red as Specific Ligand 
of Antibodies Engaged in Immune Complex
Anna Jagusiak, Joanna Rybarska, Barbara Piekarska, Barbara Stopa, 
and Leszek Konieczny
Abstract Supramolecular Congo red has been used to validate long-lasting theo-
ries regarding intramolecular signaling in antibodies and its relation to activation of 
the complement system. Strong enhancement of antigen-antibody complexation 
resulting from the binding of supramolecular ligands enables also polyclonal anti-
bodies having intermediate affinity to trigger complement cascade apart of high 
affinity antibody fraction. This would not have been possible in the absence of 
Congo red. The property of antibodies provides specifically their ability to trigger 
the complement system allowed when sufficient structural strain is produced by 
antigen complexation provides an evidence of intramolecular signaling.
The selective complexation of supramolecular ligands with antibodies engaged 
in immune complexes enables their using as carriers of drugs in immunotargeting 
system.
Keywords Intramolecular immunological signal • Complement activation • IgG V 
domain stability • N-terminal fragment • Enhancement of antigen binding • Congo 
red as carrier of drugs • Immunotargeting system • Congo red selective complex-
ation of antibodies in immune complexes
Self-associating organic molecules which form ribbonlike micellar structures may, 
owing to their structural characteristics, penetrate inside proteins and form stable 
complexes. Such penetration is possible in areas of the protein which have been 
destabilized, either temporarily or permanently  – such as antibody/antigen com-
plexes. Since Congo red (CR) has been used in research as the most typical 
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supramolecular protein ligand, the presented experiments and analysis also focus on 
this particular dye. CR binds strongly to antibodies, enabling us to study (among 
others) intramolecular signaling related to complement system activation. What is 
more, the mutual affinity of CR and immune complexes paves the way towards 
immunotargeting, i.e. targeted delivery of drugs. This is due to the fact that supra-
molecular CR – a micelle-like structure – may intercalate foreign bodies, including 
drug molecules. Congo red does not react with free antibodies – it is only capable 
of binding to antibody/antigen complexes where structure of antibody undergoes 
some alteration due to interaction with the antigen. Any potential drugintercalated 
into the CR micelle can thus be delivered to an area where the antigen is plentiful, 
ensuring targeted action. This chapter discusses the presented topics in detail.
2.1  Looking for Evidence of Postulated Intra-molecular 
Immunological Signaling
Once the structure of immunoglobulins has been divined, it soon became clear that 
their Fab and Fc fragments play differing roles in the process of triggering immuno-
logical response. While the Fab fragment selectively binds to the antigen, the Fc 
fragment – separated by a hinge – appears to be involved in triggering complement 
system activation through complexation of the C1q subcomponent. Notably, the 
Fab-antigen interaction is independent of Fc and proceeds even when the Fc frag-
ment has been removed by digestion [1, 2].
The complement system is a collection of proteins which attack and destroy cells 
recognized as alien by the immune complex. Strict control over this mechanism is 
critical for homeostasis and therefore represents an important study subject in 
 medical research. In accordance with prevalent views, such control is maintained by 
intramolecular rearrangements which carry information from Fab to Fc, and then 
onwards to C1q (Fig. 2.1).
Fig. 2.1 Schematic 
depiction of the 
intramolecular signaling 
pathway inside the 
antibody (dashed line)
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Nevertheless, despite significant effort by many leading researchers, the specifics 
of this mechanism have proven exceedingly difficult to elucidate and some uncer-
tainties persist. In attempting to explain intramolecular signaling, analysts initially 
focused on the hinge region which links Fab and Fc. Experimental data indicates 
that subclasses of immunoglobulins which differ with respect to the composition of 
this hinge region also exhibit variable efficiency of Fab-to-Fc signal transmission, 
and moreover that reduction of the disulfide bond in the hinge region prevents suc-
cessful activation of the complement system [3–5]. In turn, some attention was 
directed towards structural strain in the antibody molecule, produced by antigen 
binding and regarded as a possible signal carrier. This view is embodied in the so- 
called distortive mechanism theory. Another competing theory proposed an “all or 
none” switching mechanism, i.e. an allosteric model based on the assumption that 
immunoglobulins are, in fact, allosteric [6].
Since none of the presented models succeeded in providing a satisfactory expla-
nation, further analysis was needed. Some researchers noted the fact that, under 
ordinary circumstances, the formation of an active immune complex involves many 
different antibodies, and that complement activation requires local concentration of 
Fc fragments. This so-called associative model appeared to explain the signaling 
puzzle to a sufficient degree, particularly given the lack of evidence favoring intra-
molecular signaling [7, 8]. Earlier theories were swept aside and the issue appeared 
solved. This situation persisted for many years, until scientists learned how to pro-
duce monoclonal antibodies via crystallization of Fab fragments cleaved from the 
IgG molecule, and formulated new analysis protocols based on the use of small 
antigens (haptens) [9–11]. Surprisingly, these studies produced little in the way of 
useful results. Structural changes appeared small, even negligible – again suggest-
ing that intramolecular signaling must somehow involve torsional effects, which 
emerge only when the antigen is bound to a complete, two-arm antibody.
Spectacular progress in genetics achieved in the 1980s, particularly the ability to 
synthesize arbitrarily modified antibodies, brought new hope of understanding the 
purported intramolecular signaling mechanism. Still however, despite some focus 
on the interaction of CH1 and CH2 domains, the problem of signal remained practi-
cally unsolved [12–14].
Our research group decided to attack the problem through chemical recombina-
tion of antibodies by digestion, reduction and re-joining of immunoglobulin frag-
ments solely by disulfide bonds. The goal was to determine whether this kind of 
modified structure would retain the ability to carry the signal to Fc, despite major 
alterations in the hinge region. This process is illustrated in Fig. 2.2.
While the “full” two-arm molecule constructed from free Fab and Fc fragments 
exhibited complement activation potential (to a limited degree), its one-arm equiva-
lent proved entirely inert. This suggested that even a deficient antibody may trans-
mit the signal, if only suitable conditions exist for structural strain to emerge. 
Nevertheless, the participation of the hinge region in signal transmission remained 
a mystery [3, 15, 16].
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2.2  Evidences of Intramolecular Signaling Supplied by Using 
Congo Red
A whole new approach to the problem was enabled by the use of CR, based on our 
team’s original concept. While CR had long been known as a useful amyloid stain, 
its interaction with amyloids was explained as individual molecules attaching them-
selves to specific binding sites which recognize the dye. In contrast, our study 
revealed that CR may form complexes with a wide variety of proteins and that it 
does so as a supramolecular ligand – i.e. a distinct structure consisting of many 
associated dye molecules acting as a single unit [17–25].
Fig. 2.2 Schematic view: (A and B) Controlled formation of linking disulfide bonds. (C) 
Production of recombinant IgG
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An important breakthrough occurred when CR was found to interact with 
immune complexes, but not with free antibodies. This phenomenon shed new light 
on the intramolecular signaling pathways leading to complement system activation. 
Such selective binding suggested that CR is capable of anchoring itself in the V 
domain of the antibody, which also happens to be the site of the greatest structural 
strain resulting from antigen complexation. Furthermore, the V domain also houses 
the N-terminal fragment, which, by default, is relatively unstable (Fig.  2.3) 
[26–28].
Confirmation of this theory was provided by analyzing the complexation poten-
tial of CR vs. light chain dimers progressively destabilized through heating or 
increased concentrations of the dye. The displacement of the N-terminal fragment 
from its packing locus “opens up” the V domain, enabling the supramolecular dye 
to penetrate and anchor itself in its interior. Under experimental conditions, the first 
complexes to emerge involve ligands composed of four molecules. As the dye 
 concentration increases, the ligand may grow to include up to eight dye molecules 
(Fig. 2.4A, B respectively). This is evidenced by electrophoresis, where larger com-
Fig. 2.3 V domain of the 
L chain lambda, with its 
hightlighted N-terminal 
fragment covering gap 
created by its removal. 
Space filling model
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plexes migrate faster due to their greater charge (contributed by CR). In each case, 
the trigger for complexation appears to be the N-terminal fragment, which is dis-
placed from its packing locus and replaced by the supramolecular ligand. The dis-
placed N-terminal fragment subsequently becomes susceptible to digestion [26, 
29–31].
CR/light chain complexation may be accelerated by heating, which further per-
turbs the N-terminal fragment. In contrast, when dealing with immune complexes, 
complexation appears to be induced by structural strain resulting from antigen bind-
Fig. 2.4 Complexation of L chain dimer with CR (A) Light chain V domain. (B) Thermally gener-
ated complexes of CR with the L chain V domain presented by corresponding models. (C) V 
domain deprived of its N-terminal fragment through digestion. Agarose electrophoresis of L chains 
induced to form complexes with CR upon the stepwise increasing temperature
A. Jagusiak et al.
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ing. This phenomenon, however, only emerges in complete two-arm antibodies, 
attaching themselves to antigen determinants located randomly on the cell surface. 
Neither isolated Fab fragments nor their dimers are capable of binding CR, even in 
their complexed state. This proves that the antibody-antigen reaction is not directly 
responsible for the affinity to CR, and that dye complexation requires structural 
strain in the antibody molecule [26, 29–31].
CR is complexed by whole antibodies in complex with haptens, but only when 
they are fixed on a solid surface, i.e. under conditions which lead to structural strain 
in bivalent antibodies.
CR also binds to anti-TNP antibodies linked by a hapten if the hapten itself is 
bivalent and creates strain in the antibodies it links (e.g. oxidized glutathione with 
amino groups substituted with TNP – Fig. 2.5).
This can be confirmed under electrophoresis, since the antibodies bound by the 
binary hapten form immune complexes, become soluble and migrate more rapidly 
when treated with CR. Their number grows as the concentration of the hapten 
increases, eventually reaching a maximum beyond which a falloff is expected 
(Fig. 2.6) – due to the fact that when the hapten is overly abundant, it becomes mon-
ovalent and therefore produces no strain in the attached antibodies (Fig. 2.5) [32].
The link between CR and immune complexes exhibits one more remarkable 
property: it turns out that complexation of CRgreatly enhances theantigen/
antibodycomplexation capabilities. This is evidenced by a significant increase in 
the fraction of antibodies involved in immune complexes, especially in relation to 
low- affinity antibodies which are naturally present in the polyclonal serum. It 
should be noted that the serum contains many different types of antibodies with 
Fig. 2.5 Immune complexation of antibodies linked by binary haptens (A) and breakage of 
immune complexes caused by overabundance of hapten particles (B)
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varying degrees of affinity – due to the inherent randomness in the antibody synthe-
sis process. Low-affinity antibodies cannot form stable immune complexes and are 
washed out in the absence of CR. When the dye is present, their ability to bind 
antigens increases and the number of immune complexes per unit of volume grows 
(Fig. 2.7 A, B).
At this point it would be useful to determine the mechanism which drives 
increased complexation capabilities in the presence of CR, and also to find out 
whether such upregulation is accompanied by the corresponding increase in com-
plement system activity (which would prove the existence of an intramolecular 
signal).
The assumption that, by binding its natural biological ligand, the protein under-
goes structural rearrangement which favors penetration and complexation of supra-
molecular dye would explain why the ligand cannot be easily released once the 
protein-dye complex has formed. This phenomenon appears actual in situations 
Fig. 2.6 Experimental evidence of formation soluble complexes with CR by binary hapten-linked 
antibodies (as depicted in Fig. 2.5). Left to right: increasing hapten concentrations. The mobile 
fraction (indicated by the arrow) comprises soluble immune complexes which have gained the 
ability to bind CR (Reproduction by permission – J Physiology and Pharmacology)
A. Jagusiak et al.
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Fig. 2.7 Profiles presenting: (A) Increase in the quantity of erythrocyte-agglutinating antibodies 
under increasing concentrations of CR. High-affinity antibodies are capable of agglutinating cells 
in the absence of the dye. Anti-SRBC antibodies complex tagged by 125I. High affinity antibodies – 
fraction non removable by washing. Shadowed area – fraction of highest affinity. (B) Enhancement 
of antibody/antigen interaction by CR, proving that the effect is independent of the type of antigen 
and specificity of the antibody (Reproduction by permission  – Archivum Immunologiae and 
Therapie Experimentalis)
2 Supramolecular Congo Red as Specific Ligand of Antibodies Engaged in Immune…
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where irreversibility is finally expected – immune complexation, C1q binding etc. 
On the other hand, the same phenomenon would tend to inhibit the action of 
enzymes where the ligand must be released following catalysis. Indeed, such inhibi-
tion has been confirmed in the scope of complement activation which depends on 
the action of convertases [33].
The observed enhancement of antibody/antigen complexation capabilities may 
also be due to another factor: increased flexibility of the V domain, caused by pen-
etration of a large noncovalently stabilized ligand to packing cavity of the replaced 
N-terminal fragment, bestowing greater internal mobility upon the domain (particu-
larly its CDR loops) and therefore enabling them to align themselves to the antigen 
with greater accuracy [34].
The discovery and subsequent theoretical study of antigen complexation 
enhancement triggered by CR creates new possibilities with regard to analysis of 
intramolecular signal leading to complement system activation  – assuming that 
such signal exists. Due to inhibition of convertase (and therefore of the complement 
system) by CR, measured as the efficiency of hemolysis, the signal transfer stage 
(immune complex/C1q) has been separated from the remainder of the activation 
cascade, including convertase. This reveals activation potential, since both the 
immune complex and the subsequent complex with C1q are insoluble and may 
therefore be separated from excess CR by washing, then combined with the remain-
ing components of the complement system, thus preventing undesirable inhibition. 
To this end we have employed a commercial-grade C1q reagent (QUIDEL USA) 
and, separately, a serum containing complement system components but deprived of 
C1q (QUIDEL USA).
Once the excess dye has been washed out, the remaining insoluble complexes 
(immune complex and immune-C1q complex) prove capable of activating the com-
plement system, triggering hemolysis in C1q-deprived serum. Figure 2.8 presents 
the results of this experiment. Confirmation of complement system activation 
reveals the role of CR in the process and confirms the presence of intramolecular 
signaling.
The immune complex (agglutinate) binds antibodies with varying affinity for red 
cells which participate in the immune response (SRBC/anti-SRBC). Weak (low- 
affinity) antibodies are quickly washed out in the absence of CR. The remaining 
complexes contain antibodies with strong or moderate affinity. The introduction of 
CR stabilizes the immune complexes formed by weak antibodies, allowing them to 
remain in the agglutinate. Nevertheless, such antibodies remain incapable of trig-
gering hemolysis even when CR is present. Their properties may be studied by 
analyzing wash-out samples. Of course, antibodies which resist washing out are 
also characterized by variable affinity: the group includes strong (high-affinity) 
antibodies which do not require CR to form stable complexes and trigger hemolysis, 
but also weak (low-affinity) antibodies stabilized by CR but still unable to trigger 
hemolysis. The specific affinity threshold established by the wash-out procedure is 
somewhat arbitrary and depends on a number of conditions. It is assumed that CR 
account for approximately 50% of the washout-resistant pool. Interestingly, this 
group contains also antibodies which are unable to trigger complement activation, 
A. Jagusiak et al.
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but which gain this ability by interacting with CR. This suggests that a sufficiently 
powerful intramolecular signal may only be generated by “strong” antibodies which 
incur significant structural strain when binding the antigen. This natural threshold 
appears evolutionarily conditioned to prevent accidental thus potentially dangerous 
activation of the complement system [35–38].
Fig. 2.8 Role of CR in amplifying the complement activation signal. Model view of the process 
(left-hand column). The efficiency of erythrocyte hemolysis by the complement system depends on 
CR activation of the signaling pathway. Selective action of CR upon successive components of the 
signal pathway has been marked in red. A – immune complex (anti-SRBC antibodies not treated 
with CR); B – antibodies selectively activated by CR; C – C1q; D – C1q selectively activated by 
CR; E – serum containing all components of the complement system except C1q. Participation of 
anti-SRBC polyclonal serum antibodies in agglutination and hemolysis is shown on the right
2 Supramolecular Congo Red as Specific Ligand of Antibodies Engaged in Immune…
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While CR helps explains the signaling mechanism, the origin of the signal itself 
remains an open question. Since it seems improbable for both V domains (VH and 
VL) to react to structural strain in the same way, antigen complexation induces tor-
sional stress in the Fab fragment [39]. The resulting rotation uncouples Fc from Fab 
and allows the former to bind to C1q. This is important, since in the immune com-
plex both the antibodies and their Fc fragments are oriented randomly, which would 
otherwise hamper complexation of C1q. The uncoupling provides Fc with rotational 
freedom and enables the link to be established easier (Fig. 2.9).
In this way, the use of a supramolecular dye approaches understanding both the 
function and the purpose of intramolecular signaling.
2.3  Application of Congo Red for Immunotargeting
The fact that CR selectively binds to antibody/antigen complexes creates an inter-
esting opportunity with regard to targeted drug delivery. CR is not only capable of 
recognizing the immune complex, but – owing to its supramolecular nature – inter-
calate various drug particles, acting then as a carrier. Such intercalation should not 
be regarded as simple mixing of dye and drug molecules – it is more akin to solva-
tion, which involves close interaction between the solvent and the solute. If the 
solute is structurally flat and presents a planar arrangement of aromatic rings, it can 
be easily intercalated into the CR micelle. This effect is further enhanced if the sol-
ute is positively charged (Fig. 2.10) [34, 40, 41].
The model presented in this chapter comprises CR and rhodamin B (Fig. 2.10). 
Interaction between both dyes is evidenced by tracking the release of rhodamine B 
from a dialysis bag in the absence of CR and in a system where both dyes are com-
bined via intercalation. It is readily evident that rhodamine B – itself a supramolecu-
Fig. 2.9 Complexed antibodies showing random placement and orientation of Fc fragments. 
Arrows indicate the need for rotation, facilitating contact with C1q. This is enabled by intramo-
lecular signaling which increases the mobility of Fc fragments
A. Jagusiak et al.
33
lar system, but with weaker self-association tendencies – becomes nearly impervious 
to dialysis when CR is present. Additional complexes comprising supramolecular 
dyes and various foreign molecules, analyzed using the dialysis method, are listed 
in table shown in Fig. 2.11, and are compared to the model CR/rhodamine B com-
plex. Where analysis suggests similar stability of both complexes, a value of 1 is 
listed. Figure 2.11 presents selected compounds which form co-micellar structures 
with CR, listing their stability [42]. It seems clear that both the spatial structure and 
electric charge play an important role.
To further confirm the carrier hypothesis, our analysis focused on a specific 
immune complex, i.e. agglutination of sheep erythrocytes capable of binding supra-
molecular ligands. Figure 2.12 presents a visualization of the agglutinate, following 
addition and subsequent washing out of CR with intercalated rhodamine B [43]. 
Strong fluorescence of rhodamine B overcomes CR absorption and can be clearly 
seen along boundaries of agglutinated erythrocytes. This proves that the antibodies 
involved in agglutination (immune complexes) are bound to the CR/rhodamine B 
aggregate. Notably, CR does not react with free antibodies  – only antibodies 
engaged in immune complexation can bind the dye. In vitro analysis therefore pro-
vides evidence of the ability of supramolecular dye to serve as a vehicle for targeted 
delivery of drugs.
Fig. 2.10 Evidenced by dialysis arresting of rhodamine B (Rd) by supramolecular CR (intercala-
tion), compared to progressive reduction in the concentration of free rhodamine B
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Fig. 2.11 Examples of structures readily intercalated by supramolecular CR due to their planar 
structure and/or positive charge. Complexation tendency ranged 0–1. (Reproduction by permis-
sion – J Physiology and Pharmacology)
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It should be noted that in vitro test results do not always translate into similar 
outcomes in vivo. Successful use of supramolecular drug carriers in living  organisms 
remains a complex problem due to undesirable reactions with serum proteins, par-
ticularly albumin. To determine whether the presented method is feasible, an Arthus 
reaction has been triggered in a rabbit host – i.e. the TNP antigen (ghosts of rabbit 
red blood cells conjugated with human IgG) was injected into the earlobe of an 
sensitized rabbit, producing local inflammation caused by aggregation of immune 
complexes. The other ear was subsequently injected with 2.5 ml 5 mg/ml) isotonic 
steryl CR solution. The ear where the Arthus reaction had originally been triggered 
was then backlit for photographic documentation (the rabbit’s thin earlobe is easily 
penetrated by visible light, simplifying the process). Unfortunately, the unaided 
human eye is unable to distinguish between CR and hemoglobin – the blood present 
in the vessels in earlobe produces an color image similar to CR. Enhanced visibility 
of small blood vessels suggests that an inflammatory process is ongoing, which 
further hampers attempts to visualize dye accumulations. Effective analysis there-
fore required the use of specially prepared spectroscopic filters (the spectra of CR 
and hemoglobin differ somewhat).
Figure 2.13 presents the backlit tissue fragment with spectroscopic filters applied. 
The modified color scale enables us to easily distinguish the dye and hemoglobin 
(filter spectra are also presented, showing which wavelengths have been blocked). 
As expected, the dye is attracted to the antigen injection site, where the immune 
complex can be found. The experiment also highlights the kinetic characteristics of 
CR absorption and subsequent removal, showing how the proposed transport sys-
tem may function in practice (Fig. 2.14).
Fig. 2.12 Agglutination in the SRBC/anti-SRBC system produced by antibodies in complex with 
CR and rhodamine B intercalated. (A) not agglutinated red cells – control sample; (B and C) – 
agglutinated red cells  – UV light (Reproduction by permission  – Folia Histochemica et 
Cytobiologica)
2 Supramolecular Congo Red as Specific Ligand of Antibodies Engaged in Immune…
36
Fig. 2.13 Migration of CR to areas of immune complexation (Arthus reaction induced in rabbite-
arlobe). Spectroscopic filters depicted above each column were used to differentiate CR and hemo-
globin. Column A – spectra of hemoglobin and CR, column B and C – spectra with filters used 
(4–6) [43] a, b, c - three independent experiments. (Reproduced by permission – Folia Histochemica 
et Cytobiologica)
A. Jagusiak et al.
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2.4  Toxicity of CR and Its Applicability for Immunotargeting
An important practical advantage of CR, as well as of other structurally similar 
supramolecular systems, is their relatively low toxicity. Supramolecular dye aggre-
gations do not readily penetrate cellular membranes, and are easily excreted, along 
with the surplus of any intercalated substance (Fig. 2.15). Nevertheless, intestinal 
excretion of CR has been linked to carcinogenesis – most likely due to bacterial 
reduction of the dye, producing benzidine (a known carcinogen). This undesirable 
effect may be mitigated by administering a cellulose-rich diet, since cellulose 
eagerly binds CR and protects it from structural changes, including reduction.
In addition to its immune complexation potential, CR is also being studied in the 
context of amyloidaffinity, although the presented applications of supramolecular 
Fig. 2.14 CR accumulation kinetics in the Arthus reaction area: A  – 1 h35′; B  – 3 h30′; C  – 
4 h35′; D – 5 h; E – 9 h30′; F – 26 h30′; G – 52 h35′; H – 72 h20′; I – 14 days (Reproduced by 
permission – Folia Histochemica et Cytobiologica)
2 Supramolecular Congo Red as Specific Ligand of Antibodies Engaged in Immune…
38
ligands are based on laboratory experiments. Practical medical applications would 
require further, independent research.
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Chapter 3
Protein Conditioning for Binding Congo Red 
and Other Supramolecular Ligands
Grzegorz Zemanek, Anna Jagusiak, Joanna Rybarska, Piotr Piwowar, 
Katarzyna Chłopaś, and Irena Roterman
Abstract Self-assembled organic compounds which form ribbon-like micellar 
clusters may attach themselves to proteins, penetrating in areas of low stability. 
Such complexation involves regions other than the protein’s natural binding site. 
The supramolecular ligand adheres to beta folds or random coils which become 
susceptible to complexation as a result of function-related structural changes – e.g. 
antibodies engaged in immune complexes or acute phase proteins. However, even 
seemingly unsusceptible helical proteins may bind Congo red if they include cha-
meleon sequences (short peptide fragments capable of adopting different secondary 
conformations depending on environmental conditions). Examples of such proteins 
include hemoglobin and albumin. Complexation of supramolecular Congo red is 
often associated with increased fluorescence, indicating breakdown of ligand 
micelles in the complex. This phenomenon may be used in diagnostic tests.
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3.1  Natural Susceptibility of Proteins to Bind Congo Red
As remarked in Chaps. 1 and 2, supramolecular micellar systems may form com-
plexes with proteins by penetrating in areas other than the active site. This process 
is conditioned by local instabilities in the protein structure [1, 2].
As a rule not all parts of a protein molecule are equally stable. Local instabilities 
are usually not significant enough to enable direct penetration of a large ligand con-
sisting of many associated molecules. Such instabilities can, however, be artificially 
exacerbated, e.g. through heating [3]. Under natural conditions Congo red (CR) is 
spontaneously bound by partly unfolded proteins capable of forming aggregations – 
such as amyloids and some abnormal [4–9]. While aberrant (unstable) proteins are 
usually eliminated before they can leave their parent cell [10–13], under certain 
circumstances  – such as mass synthesis of light chains associated with multiple 
myeloma – they can be detected in circulation (Fig. 3.1) [14–19].
On the other hand, proteins destabilized partly through complexation of their 
“intended” natural ligands are commonly found in bodily fluids, especially in blood 
serum. Such proteins usually acquire the ability to bind CR. Examples include 
acute-phase proteins, conditioned to capture and eliminate other proteins whose 
presence in the bloodstream is harmful – e.g. proteolytic enzymes (which – due to 
their specific mechanism of action – may penetrate from the digestive tract or be 
released by necrotic cells), as well as hemoglobin, which has undesirable catalytic 
Fig. 3.1 Standard 
electrophoretic separation 
of serum proteins with 
revealed monoclonal 
fractions (thick bands in 
columns 9–12 – mostly L 
chains)
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properties and should not be present in the bloodstream in its unbound form. These 
acute phase complexes are similar to antibody/ligand complexes – by binding its 
natural ligand the protein undergoes structural deformations which facilitate pene-
tration of an additional supramolecular ligand [20]. Acute phase complexes are 
short-lived, since they are recognized and removed by liver enzymes and phago-
cytes. Nevertheless, as long as the underlying cause persists, the blood serum will 
always contain proteins capable of association with CR. The specific composition 
of acute phase proteins present depend on the ongoing pathological processes. 
Acute phase proteins include serpins, haptoglobin, ceruloplasmin, ferritin, comple-
ment factors C3 and C4, as well as albumin, prealbumin and transferrin [21] 
(although note that in the last three cases pathological processes do not increase the 
concentration of the corresponding protein, but decrease it instead).
The ability of CR to bind to serum proteins is readily evidenced by agarose gel 
electrophoresis where the supramolecular ligand is added to the column at a certain 
stage of the process, accelerating migration of the affected proteins. Figure 3.2 pres-
ents a typical scenario where serum proteins are subjected to two-stage 
 electrophoresis on agarose gel, with the second stage carried out in a perpendicular 
direction to the first, in the presence of CR (red band in Fig. 3.2D) [3, 21].
Fig. 3.2 Two-directional agarose electrophoresis with exposed CR binding fractions dislocated 
over the diagonal line which includes non-binding serum proteins (A, B, C - three independent 
examples). (D) Presents the basis for this method. The red band indicates CR, which is spread on 
the agarose plate before the second electrophoretic step
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The dye quickly migrates towards the anode and bypasses most proteins, except 
those structurally conditioned to bind the dye. As a result, migration of the affected 
proteins is accelerated and those proteins are found above the diagonal line which 
collects non bonding proteins. The mobility imparted by CR upon the target protein 
depends on the number of associated dye molecules and the molecular weight of the 
protein itself – hence the variable results observed under electrophoresis. The pre-
sented technique could have important diagnostic applications; here, however, our 
goal is merely to present the interaction of CR with serum proteins in order to 
explain the mechanism of supramolecular complexation. Regarding acute phase 
proteins, CR complexation is particularly evident in the case of proteins which 
always exhibit some form of activity, but whose activity in pathological conditions 
is significantly increased and/or altered.
Some proteins can bind supramolecular ligands even in the absence of a com-
plexation partner which would account for structural rearrangement and reduction 
in stability. This includes albumin. Owing to its function, albumin is capable of 
binding various anionic compounds, of which the dye is an example. CR is further-
more capable of associating with amyloidogenic apolipoproteins [22–26].
3.2  Interaction of Congo Red with Helical Structures 
of Polypeptides
With regard to CR complexation capabilities, haptoglobin represents another inter-
esting research target. The protein binds free hemoglobin, dissociating it into its 
alpha/beta subunits, but persists as a bridge between both halves [27]. The resulting 
structure can form complexes with CR. The dye itself also causes dissociation of 
hemoglobin into identical alpha/beta subunits, but releases them without forming a 
bridge. Hemoglobin is a typical allosteric protein, with the associated instability 
most likely concentrated in its alpha/beta interface region. This instability promotes 
complexation of supramolecular ligands. It appears that CR induces local changes 
in the alpha-helix structure of the subunit alpha of hemoglobin, transforming it into 
a beta fold or a random coil, which aids complexation. The process is reversible – 
adsorption of CR (e.g. on the P15 gel, which strongly binds the dye) yields normal 
hemoglobin tetramers. Increasing concentrations of the dye produce stronger dis-
sociation – see Fig. 3.3 for electrophoretic images of ½ Hb/CR complexation activ-
ity. The effect is independently confirmed by DLS measurements, revealing in the 
mixture the reaction products of lower molecular weight (Fig. 3.4).
Dissociation of hemoglobin can also be observed when treating hemoglobin 
crystals (horse) with CR. The resulting dissolution proves that, as a result of binding 
the dye, the protein undergoes structural changes which prevent crystallization 
(Fig. 3.5) [28–31].
Probable complexation loci in hemoglobin subunits have been identified by 
locating structurally unstable alpha folds, which also exhibit measurable propensity 
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towards adopting beta or random coil conformations. Such folds may favor penetra-
tion of the supramolecular ligand, altering their own conformation in the process 
and producing finally stable bond. Comparative analysis has been performed by 
querying a database of chameleon sequences (i.e. sequences which may adopt either 
alpha or beta conformations, depending on local conditions) [32]. For each tetra-
peptide, the database lists the corresponding probabilities of encountering alpha, 
beta and random coil conformations in actual proteins – this enables identification 
of fragments of the hemoglobin chain which may potentially transit to beta folds or 
random coil.
Results are presented in Fig. 3.6 as a sequence of bar charts illustrating the struc-
tural propensities of each residue sequence.
While chameleon sequences are found in both subunits of the hemoglobin chain, 
their placement in the alpha subunit appears to be more favorable for binding CR – 
they are located close to one another and provide a convenient pocket with beta or 
Fig. 3.3 Complexation of 
dog hemoglobin with CR. 
Bars representing 
decreasing amount of dog 
hemoglobin (slow moving 
electrophoretic fraction) 
caused by its transfer to the 
fast-migrating complex 
with CR (inset). The CR 
dye concentrations in Hb 





Fig. 3.4 DLS analysis 
revealing a shift towards 
lower-mass molecules 
following interaction of 
hemoglobin with CR (red 
bar), confirming 
dissociation of the protein 
into subunits
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random folds found on either side of the ligand. Experimental evidence suggests 
that CR penetrates the protein as a supramolecular ligand, wedging itself between 
parallel folds as long as such folds are not tightly packed and may be induced to 
adopt beta or random coil conformations. In contrast, helical folds do not support 
complexation of CR due to steric clashes. Regarding the alpha subunit, chameleon 
fragments are found in areas referred to as the G, H and FG helices, all located in 
close proximity of the heme. Structural rearrangement caused by complexation of 
CR therefore causes dissociation of the protein.
Figure 3.7 provides a space-filling depiction of the abovementioned fragments, 
while Fig. 3.8 illustrates the transition of unstable helices into beta folds or random 
coils, using albumin as an example. While albumin is ordinarily a helical protein, 
Fig. 3.5 Disintegration of hemoglobin crystals (horse) upon interaction with CR observed under 
a microscope, in visible light (A–D) and UV (E and F)
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complexation of CR produces a notable conformational shift in favor of beta folds 
and random coils. Interestingly, similar interaction with EB and TB does not have a 
similar effect on the secondary conformation of the albumin chain [26] (Fig. 3.8).
It should be noted that the CR micelle is much more cohesive than its EB coun-
terpart and therefore exerts a greater structural influence upon its surroundings. As 
a result, this relatively stable supramolecular ligand may force the target protein to 
adapt to its conformational preferences. This contrasts with EB, which relies on 
natural complexation sites present in the protein and does not induce conforma-
tional changes in its alpha chains. As already remarked, such “forcing” action of CR 
affects chameleon sequences which nominally appear as helices, but may also adopt 
beta or random coil conformations. Stable alpha folds do not yield to the presence 
of CR  – although the stability threshold beyond which conformational changes 
Fig. 3.6 Bars representing 
the tendency of successive 
polypeptide chain 
fragments (numbers listed 
on the horizontal axis) of 
the human hemoglobin 
alpha subunit to adopt 
alpha, beta and random 
coil conformations 
respectively. The presented 
values are derived from the 
chameleon sequence 
database [32] (A) The 
same concerning neighbor 
amino acids (B)
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occur is not well defined. It appears that increasing the concentration of CR results 
in more cohesive micelles with greater protein penetration ability. This is suggested 
by electrophoretic migration rate which increases as the acidity of CR in solution 
grows, indicating changes in pK of sulfonic group (Fig. 3.9).
Fig. 3.7 Alpha/beta subunit of hemoglobin (3OO5 – PDB) with chameleon fragments likely to 
adopt beta and random coil conformations marked in red, and additionally presented in a space- 
filling model in the alpha subunit. The images are rotated by 90° with respect to each other
Fig. 3.8 Bars representing the decrease in the quantity of alpha folds in albumin upon binding 
supramolecular ligands – particularly CR, indicating that compactness of the ligand is critical for 
complexation
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Having induced structural changes in the protein, CR forms a complex with the 
newly produced beta fold or random coil, stabilizing the change. The dye penetra-
tion limit is determined by mutual alignment between the protein’s secondary folds 
and the dye micelle. An important factor facilitating penetration is the cohesiveness 
of the ligand itself, which – unlike the polypeptide – is not a polymer but rather an 
associate, stabilized by noncovalent interactions [33–35].
Albumin is a typical helical protein with a particularly vital role in blood serum. 
The importance of albumin is underscored by its natural concentrations and deep 
involvement in energy management processes. Albumin represents a source of 
amino acids in cases of malnutrition, but it also serves as a carrier of fatty acids. It 
is further capable of binding and transporting a variety of dyes and drugs [27]. Its 
complexation affinity for supramolecular CR and EB [26] makes it a useful study 
subject. Clearly, albumin may play a role in immunotargeting, since it is capable of 
forming complexes with supramolecular ligands doped with therapeutic agents.
The binding of supramolecular CR and EB by albumin has been confirmed by 
synthesizing co-micellar structures, i.e. supramolecular structures consisting of 
either dye mixed with a foreign compound a positively charged dye not normally 
complexed by albumin, such as rhodamine B or Janus Green, which can only be 
bound to the protein as an intercalant. In the case of rhodamine B, this effect is 
revealed by UV imaging of electrophoretic plates. The characteristic fluorescence 
of rhodamine B coincides with the location of the albumin stain, proving that the 
dye enters the protein as a component of a co-micellar structure formed by CR or 
Fig. 3.9 Fluorescent albumin spot seen on an electrophoretic plate, showing that positively 
charged rhodamine B molecules with no affinity to albumin may be introduced to it anyway via CR 
which binds rhodamine B by intercalation. Agarose electrophoresis. 1 albumin combined with CR 
and rhodamine B (complex); 2 albumin + rhodamine B; 3rhodamine B; 4 albumin + CR; 5 CR. (A) 
UV image. (B) Visible light image following reduction and protein staining
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EB (Fig. 3.10). The supramolecular nature of the ligand bound to albumin is also 
confirmed by counting the number of dye molecules attached to each albumin mol-
ecule (16–20 unit molecules in the case of CR) [26]. The link between self- 
association properties and protein complexation potential further suggests that the 
ligand functions as a supramolecular entity.
Additional insight into the specifics of CR and EB complexation with albumin is 
provided by spectro-polarimetric analysis. The complex with EB is strongly chiral, 
while the corresponding complex with CR does not exhibit chirality [26]. This sug-
gests that EB favors cis binding, while CR binds in a trans (alternating) alignment. 
The effect can be explained by referring to the structure of both dyes. In EB, all 
sulfonic groups are adjacent and bound to aromatic rings at either end of the mole-
cule and therefore aligned with its long axis. This results in mutual modification of 
Fig. 3.10 The geometry and charge distribution of CR and EB dyes, explaining the prevalence of 
the form trans in the case of CR rotamers. (A) CR cis, (B) CR trans, (C) EB
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the dissociation constant and focuses electrostatic interactions on the polar regions. 
Consequently, rotation of the molecule about its long axis does not yield any bene-
fits for self-association and can be considered irrelevant. Cis binding is likely related 
to the properties of other binding-capable substituents: the −OH and −NH2 groups. 
In contrast, in CR the location of sulfonic groups clearly favors trans binding, i.e. 
alternating alignment of symmetrical halves (Fig. 3.10).
The structure of albumin suggests that the supramolecular ligand is attracted to 
the gap between the protein’s two lobes [26]. This is where the longest non-helical 
folds can be found and where oscillatory structural changes (RMS-F) are revealed 
by molecular dynamic studies (depending on temperature), suggesting limited sta-
bility of the native secondary conformation. All these factors enable the anchoring 
of a supramolecular ligand (Fig. 3.11).
Fig. 3.11 The most unstable area of albumin (200–400 aa) estimated according to secondary 
structure predisposition. (A) Profile indicating the predisposition to adopt helical (H), beta (B) and 
random coil (RC) conformations of each chain fragment. Fragments particularly likely to adopt 
beta forms are marked on the horizontal axis (shaded areas). (B) 3D presentation of albumin, with 
highlighted fragments (red) exhibiting the greatest predisposition to adopt a beta form. (C) 200–
400 aa fragment of Hb polypeptide chain. (D) Flexibility along the polypeptide chain in albumin 
as expressed by the RMS-F parameter
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3.3  Fluorescence Property of Congo Red
Interesting conclusions may be drawn from fluorescence analysis. Free CR is gener-
ally not fluorescent; however, fluorescence appears when the dye forms complexes 
with cellulose or with certain proteins. Theoretical analysis indicates that fluores-
cence should be inhibited by self-association which increases the mobility of 
Π-electrons and besides does not produce dipoles of equal length. In turn, fluores-
cence should be expected to emerge when the micelle dissociates into individual 
molecules or (possibly) oligomers. The exact conditions which favor fluorescence 
are not known with certainty. Supramolecular CR resembles a twisted tape. In the 
absence of a complementary surface (which mirrors its twists), the ribbon may only 
adhere to other molecules locally. This disrupts the micelle and favors retention of 
individual molecules or oligomers, explaining the fluorescence observed when CR 
interacts with cellulose. Another evidence of the proposed mechanism is induced 
fluorescence which occurs when CR is dissociated by a detergent, such as cholate, 
which can be intercalated into the micelle due to its planar structure, but which lacks 
aromatic rings (Fig. 3.12).
Calculations [36] based on the assumption that the bond between CR and beta 
polysaccharides such as cellulose is mediated by the polar fragments of the dye, 
appear to suggest that the optimal arrangement would involve clustering of indi-
vidual dye molecules perpendicular to the polysaccharide chain. Although this 
Fig. 3.12 Fluorescence of CR, arising as a result of disintegration of its micellar structure by 
DMSO (dashed line), alcohols (solid gray line) urea (dotted line) and cholate (mixed dashed/dotted 
line)
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argument does not acknowledge the self-association tendencies of CR, both theories 
do account for the retention of individual CR molecules, which would explain the 
observed fluorescence. Similar dissociation of the micelle may also be observed 
when CR forms complexes with certain proteins or protein aggregates  – e.g. 
 immunoglobulins or amyloids. It may also be caused by mechanical strain and dis-
locations in proteins which form complexes with the supramolecular dye. Such a 
situation may arise e.g. when cells react via their surface receptors – mostly cadher-
ins and integrins, which have immunoglobulin-like conformations and become sus-
ceptible to CR penetration as a result of structural strain [37]. Subsequent motion of 
the cells exacerbates tension and promotes structural rearrangements, which may 
fragment the attached supramolecular ligand [38]. An example is provided by the 
reaction between monocytes and cancer cells. Monocytes recognize cancer cells as 
alien and attack them. Figure 3.13 presents visible-light and UV images of this pro-
cess. Fluorescent patches correspond to the specific areas where cancer cells are 
attacked by monocytes. The images reveal free monocytes with no signs of 
 fluorescence, as well as aggregations of monocytes clustered around cancer cells, 
with CR fluorescence clearly visible. The presented interpretation is also supported 
by induction of fluorescence through structural strain and rearrangements in anti-
bodies forming immune complexes. In order to reveal this effect, the rosetting tech-
nique has been applied [39].
This process involves monocytes which bind antibodies via their Fc receptors. 
Sheep red blood cells have been added to a solution of anti-SRBC antibodies. 
Subsequent images show monocyte rosettes entirely covered by erythrocytes, sug-
gesting even distribution of the immune complex. This indicates that conditions 
which favor CR complexation may emerge anywhere on the cell surface. When 
analyzing UV images, it becomes evident that fluorescence appears where the struc-
tural strain is greatest, fragmenting the ligand micelle into smaller units and/or indi-
vidual molecules (Fig. 3.14).
The fluorescence of CR induced in a rosette system indicates that the supramo-
lecular ligand is destabilized and partly dissociated by structural strain in its attached 
protein which does not provide a close match for the ligand’s own preferred confor-
mation [40]. Similar results are obtained when heating complexes of CR with IgG 
light chains, which usually form two distinct fractions – the slow-moving and the 
fast-moving fraction. The former fraction is represented by ligands comprised of 
four dye molecules, whereas the latter fraction includes ligands with 5–8 dye mol-
ecules per micelle. There is only minimal smearing between the pure light chain 
stain and the slow-moving fraction stain, which indicates that slow-moving com-
plexes are produced with ease. This fraction exhibits weak fluorescence. In contrast, 
the fast-moving fraction is formed slowly (preferentially at higher temperatures – 
45–55  °C) and its electrophoretic image is smeared, indicating that the complex 
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Fig. 3.13 CRfluorescence induced by cell-cell interaction (interacting monocytes and cancer 
cells) seen in UV (left column) and visible light (right column) – microscope imaging A, B, C - 
three independent examples. (Reproduced by permission of Folia Histochemica et Cytobiologica)
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grows steadily from 5 to 8 dye molecules conquering some resistance – a process 
which also progressively increases its fluorescence (Fig. 3.15). The proposed mech-
anism is therefore validated. At higher dye concentrations, the distinction between 
both fractions is less dependent on temperature. This is likely due to simultaneous 
formation of both types of complexes in an environment characterized by abun-
dance of CR.
As already discussed, supramolecular CR attaches itself to beta folds or random 
coils. This process is promoted by instabilities in the protein molecule, and, addi-
tionally, the complexation capabilities of the dye increase along with its concentra-
tion. By binding a supramolecular ligand, the protein adapts its tertiary conformation 
to the micelle; however most of the structural rearrangements which enable binding 
occur in the dye itself, and are facilitated by the noncovalent interactions between 
individual dye molecules.
Fig. 3.14 Unequal CRfluorescence distribution in rosettes seen in visible light. (A) Visible light. 
(B) Simplified model of dye complexation by antibodies in the immune system. (C and D) UV 
spectra (Reproduced by permission of Folia Histochemica et Cytobiologica)
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Chapter 4
Metal Ions Introduced to Proteins 
by Supramolecular Ligands
Olga Woźnicka, Joanna Rybarska, Anna Jagusiak, Leszek Konieczny, 
Barbara Stopa, and Irena Roterman
Abstract Congo red and other supramolecular structures may intercalate various 
foreign compounds, particularly planar ones. Such hybrid ligands, acting as a unit, 
may attach themselves to proteins and penetrate into their interior, together with any 
intercalated substances. If the intercalant is a metal complexone, a stable metallo-
protein may be formed. This chapter discusses intercalation of metal complexones 
with metal ions bound by supramolecular Congo red as a means of introducing 
contrast to amyloid-like aggregates in order to trace the initial stages of amyloido-
genesis. We investigate the applicability of Titan yellow carrying silver ions, and the 
alizarin complexone carrying tungsten and lead ions.
Keywords In vitro formed metalo-proteins • Supramolecular systems as metal ions 
carriages • Congo red and metal ions incorporation to proteins • Metal bearing 
supramolecular EM stains • Immune-complexes as Congo red target • Amyloid-like 
aggregates • EM contrast bearing Congo red • Metal ion complexation • Congo red 
and beta amyloid fibrils stained • Supramolecular systems and metal ion 
complexation
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4.1  Metal Ions in Natural Biological Systems
Many proteins, including enzymes, rely on metal ions for their biological activity. 
The ions themselves are usually transition metals, such as iron, cobalt, nickel or 
copper. They enable catalysis due to their electron structure and the ability to form 
coordinate bonds. Another commonly encountered metal is zinc – it can be found 
e.g. in proteolytic enzymes known as metalloproteinases whose peculiar complex-
ation capabilities have attracted much scientific attention.
Nearly one-third of all known enzymes include some type of metal ion. Metals 
are primarily associated with catalysis, but they also play an important part in for-
mation of specific complexes, such as oxygen binding – e.g. in hemoglobin, which 
contains iron. Metals are also encountered in transcription factors, and along many 
other biochemical pathways, such as respiration. Certain protein complexes are 
dedicated to sequestration and/or accumulation of metals (e.g. siderophilin and fer-
ritin) as well as detoxification (e.g. metallothionein).
Transition metals are sometimes referred to as “d”-electron metals due to the 
involvement of their “d” orbitals in atomic interactions. They form a variety of com-
pounds with interesting spectroscopic and magnetic properties whose practical 
applications are the subject of ongoing research [1–17]. In the cell, metals are usu-
ally found in their complexed form, either as standalone ions or inside specific pla-
nar carrier compounds encapsulated by proteins  – e.g. the porphyrin ring in 
hemoglobin. Proteins provide the capability to bind metals, isolate them from water 
and may introduce favorable steric conditions [18]. A classic example is hemoglo-
bin, which enables oxygen binding without oxidation of the bivalent iron. Combining 
metal ions with proteins enhances their catalytic potential. The search for artificial 
structures with desirable catalytic properties is an important topic in medical sci-
ence. The bond between the metal and the protein should not be random in charac-
ter, since such uncontrolled complexation is usually encountered on the protein 
surface, where the metal remains in contact with water. In order to reduce polarity, 
the ion should optimally be placed right in the pocket of the active group. In prac-
tice, however, this is a very challenging task. An interesting solution is proposed in 
[19], where a metal ion was attached to streptavidin by connecting the Ru complex 
with biotin via a carboxyl group. This resulted in catalytic activity even though the 
complexed ion was located nearly on the surface (the biotin binding cavity has a 
depth of approximately 15Ǻ, which coincides with the length of the complex) [20].
4.2  Insertion of Metal Ions into Proteins by Supramolecular 
Ligands
An entirely different approach to binding metals with proteins relies on supramo-
lecular ligands. Such ligands can form stable complexes with proteins which have 
become susceptible to penetration as a result of function-related structural changes, 
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or which possess such properties natively [21–23]. Certain proteins can be induced 
to undergo complexation with supramolecular ligands e.g. by heating, which causes 
partial unfolding of the polypeptide chain. However, only ribbonlike supramolecu-
lar structures are capable of penetrating into proteins and forming stable complexes. 
Examples include CR, EB and others [24, 25] – dyes with known affinity for amy-
loids and immune complexes [26]. Supramolecular systems (e.g. CR) may, in turn, 
intercalate a variety of planar compounds with a polyaromatic ring structure and/or 
positive charge. Hence if the intercalant itself contains a metal ion, the ion can be 
attached to the protein. As a result supramolecular ligands can bind metal ions to 
proteins by intercalating their complexons.
The supramolecular ligand usually binds outside of the protein’s active site. The 
complex is formed in the distal part of the molecule, however the ligand penetrates 
into the protein interior, where polarity is lower and no water is present – similarly 
to the active site [22, 27, 28]. Exposure of the intercalated metal ion depends on the 
structure of the resulting complex. This means that attaching metals to proteins 
seems at the moment more convenient than through the use of customized sub-
strates or enzymatic inhibitors. The ion is not delivered to the active site, but the 
resulting conformation shares some similarities with the structure of the active site, 
and may possess useful biological properties.
The goal of our team was to confirm the proposed means of attaching metals to 
proteins, and also to devise a way to equip CR – a known amyloid stain – with con-
trast for the purposes of EM imaging. The complexation of CR with amyloids is the 
subject of numerous studies [29–31]. The problem is difficult and its molecular 
underpinnings remain speculative, since CR itself is not visualized under electron 
microscopy, while amyloids – despite their ordered structure – do not attain the 
necessary level of crystallization order. One putative solution would be to add con-
trast to CR itself to visualize its distribution with respect to amyloid deposits. 
Assuming that CR binds to amyloids as a supramolecular system, the contrast could 
be introduced as a metal-containing intercalant. The proposed compound – TY – 
comprises symmetric polar groups and aromatic rings [32, 33] (Fig. 4.1). Its halves 
are linked by a tri-azo bond capable of complexing metal ions, particularly silver 
and mercury. The silver-containing complex is more convenient due to its stability 
and formation in both neutral and slightly alkaline environments. TY/Ag+ complex-
ation is also easy to detect since its spectrum differs markedly from the spectrum of 
free TY (Fig. 4.1).
The complex withstands electrophoretic dissociation in alkaline pH in a tris buf-
fer (Fig. 4.2). It dissociates in the presence of anions, yielding insoluble silver com-
pounds (solubility coefficient < 10−13), which indicates that in biological systems 
only thiol groups are effectively able to react with silver bound in the complex. A 
certain disadvantage of this complex is its notable viscosity. This is due to the spe-
cific mode of interaction between the silver ion and the tri-azene bond – it may 
involve both coordination valence electrons of silver ion, or only one, if the other 
has easy access to the tri-azene group of another dye molecule. This phenomenon 
promotes association of complexes, particularly at high dye concentrations. 
Fortunately, the viscosity of TY/Ag+ complexes is greatly decreased in the presence 
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Fig. 4.1 Spectral changes effect of silver ion complexation with TY
Inset: the formula of TY
Fig. 4.2 Agarose 
electrophoresis of dyes 
used for staining amyloids 
and amyloid-like 
aggregates. Accelerated 
migration of CR mixed 
with TY is the evidence of 
mutual complexation. 
1 – TY/Ag+, 2 – TY, 
3 – CR/TY, 4 – CR
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of CR, whose molecules separate the intercalants, preventing mutual interactions. 
Intercalation of TY enhances the contrast characteristics of CR, rendering it useful 
for EM imaging of amyloids.
Initial research involving contrast-enhanced CR has been carried out with 
amyloid- like aggregations formed by shaking of IgG light chains at increased tem-
peratures (40–45  °C), following which the precipitate was treated with the CR- 
TY- Ag+ complex. The progressive appearance of structural order can be observed 
by imaging CR, which is a selective amyloid stain. In the presented case, aggrega-
tions were formed by shaking an amyloidogenic protein (IgG light chain) in condi-
tions verging on denaturation: increased temperature and pH inconsistent with the 
protein’s isoelectric point. These conditions promote the formation of amorphous 
aggregations in which seeds of order randomly emerge – typically as short, spiraling 
threads capable of binding the supramolecular dye. Such ordering is easier to 
observe and analyze along the edges of solids and/or in fine flecks of aggregates. 
The contrast medium carried by CR greatly simplifies molecular analysis.
Figure 4.3 presents the contrast-enhanced aggregate as seen under an electron 
microscope. Accurate interpretation of results requires however carefully prepared 
samples and an optimized method – still, even at this early stage it seems evident 
that the image carries useful information. Functional optimization should involve 
formation and stability of the protein-metal complex, but also even distribution of 
CR and the intercalated contrast medium. A classic amyloid aggregation formed by 
commercially available peptides (amyloid beta) is shown in Fig. 4.4 – it appears as 
twisted strands whose thickness depends on the synthesis procedure.
The proposed approach may also be used to stain antibodies engaged in immune 
complexes, since immune complexation renders antibodies susceptible to penetra-
tion by CR [34, 35]. Figure 4.5 presents sheep red blood cell membranes (ghosts) 
broken to pieces by homogenization and then agglutinated by specific antibodies 
obtained from the sensitized rabbit (anti-SRBC serum).
Another, more universal complexon analyzed in the search for convenient meth-
ods of attaching metal ions into proteins is the alizarincomplexone (Fig.  4.6). It 
fulfills all the necessary conditions – it can bind a variety of metals and is itself 
intercalated by CR.
Unfortunately, it requires acidic conditions, since metal complexation is medi-
ated by two acetic acid residues (which undergo ionization in a neutral or basic 
environment, declining their ability to bind the metal). The problem is additionally 
exacerbated by the fact that in pH < 5 CR transitions into a chinoid compound, 
becoming insoluble. Taken together, these two phenomena establish a rather narrow 
pH range where effective complexation may take place. The alizarincomplexone 
forms complexes with cobalt, lead, nickel and with the salts of certain other metals 
such as molybdenum and nickel. Complexation is evidenced by spectral changes 
(Figs. 4.7 and 4.8). Complexes persist under electrophoresis.
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Tungsten and lead complexes may serve as a contrast medium when intercalated 
by CR in 0.05 M acetate buffer (pH = 5.9).
The resulting EM images reveal various modes of aggregation, depending on the 
target polypeptide chain and environmental conditions. In most cases the aggregate 
is amorphous but contains islands of ordered structures, seen as granular chains of 
varying length, with longer chains often spirally twisted. When viewed in polarized 
light, these ordered fragments exhibit birefringence and glow, indicating that they 
constitute of ordered amyloid precursors (Figs.  4.9, 4.10, 4.11 and 4.12). 
Nevertheless, a detailed description of their structure requires further research.
Fig. 4.3 Amyloid-like particles. (A and B) The edge fragments contrasted with complex CR/TY/
Ag+ used as the stain. (C) Aggregates seen in the polarised light
O. Woźnicka et al.
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4.3  Conclusions
Transition metal ions exhibit complexation capabilities which may be of significant 
practical importance. Biological applications focus on introduction of such ions into 
proteins, where they exhibit greater reactivity than in their unbound form. The role 
of the protein in this process is not entirely clear, although changes in environmental 
factors (particularly reduction in polarity) appear to play an important role. Under 
these assumptions, it is not necessary for the metal ion to be placed in the active site, 
since this is usually not the only area characterized by low polarity. Internalization 
of metal ions is facilitated by supramolecular ligands, capable of penetrating into 
proteins in unstable areas basically other than the active site. Such ligands can serve 
as carriers for a variety of organic molecules, including those which contain metal 
ions. The metal-containing compound is attached to the ligand via intercalation, 
which naturally leads us to search for suitable metal complexones, able to form 
strong bonds with CR. Examples include TY and the alizarin complexone. 
Confirmation of the metal-protein bond is provided by microscopic imaging of 
amyloid-like aggregations formed by the IgG light chain stained by CR in complex 
with TY/silver ions.
EM images reveal amorphous aggregations which contain ordered structures 
capable of binding the contrast medium. Such structures typically adopt the form of 
Fig. 4.4 Amyloid Beta 
1–40 (Sigma) derived 
fibrils stained by (CR/TY/
Ag+) complex seen in EM 
picture. Supplement 
picture below – the 
enlargement of fibrils
4 Metal Ions Introduced to Proteins by Supramolecular Ligands
68
twisted strands and function as seeds for amyloid transformation. In addition to bulk 
solids (which are difficult to study with EM), some aggregates also adopt the form 
of thin membranes, exposing the contrast medium and confirming that supramo-
lecular ligands may successfully attach metal ions to proteins. Thus, the location of 
CR concentrations in microscopic images reveals the shape of the analyzed object. 
While amyloids are known to adopt various structures, depending on the 
 conformation of the unit protein and on environmental conditions, all such  structures 
retain the ability to bind CR (Figs. 4.7, 4.8, 4.9 and 4.10) show fragments of amy-
loid-like aggregates with portions containing ordered structures exposed by con-
trast. As can be seen, the bulk of the aggregate remains amorphous and incapable of 
Fig. 4.5 Agglutinates of fragmented by homogenisation erythrocyte ghosts (SRBC) stained by 
CR/TY/Ag+. Insets – enlarged fragments
O. Woźnicka et al.
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binding the dye. Due to its thickness, it produces some darkening in the resulting 
images, but even so the contrast is clearly discernible. The ordered forms constitute 
seeds for amyloid transformation, which explains their ability to bind CR.
Aggregation is mediated by light chain V domains, which are less stable than the 
corresponding C domains. Prior to aggregation, V domains undergo partial  unfolding 
initiated by displacement of N-terminal chain. This uncovers the interior of domains 
[21] making available a pocket in which the CR aggregate may anchor itself. It 
appears that unfolding affects the so-called upper core [36, 37] and occurs 
 symmetrically in the dimeric structure of the protein. Partly unfolded V domains 
may subsequently form beta-beta bonds with adjacent molecules, creating a fibril. 
Fig. 4.6 Spectral changes associating the complexation of alisarine complexon (AC) with tung-
state ion – A and lead ion – B
4 Metal Ions Introduced to Proteins by Supramolecular Ligands
70
The role of the lower core (responsible for stabilization of the inter-chain interface) 
in this process is not clear, as is its involvement in structural rearrangements in the 
V domain. It seems that fibrils can form in either case; however, strand-like products 
are expected to possess different properties. Molecular interpretation of CR binding 
to amyloid fibrils formed by commercially available Amyloid Beta peptide 40 
requires further study. In contrast to native proteins which undergo structural rear-
rangements facilitating penetration of a supramolecular ligand, the packing of Beta 
peptide 40 derived amyloid fibrils is tight and uniform. The dye may potentially 
penetrate in areas where the fibril is sheared or otherwise structurally disrupted. 
Fig. 4.7 Spectral changes presented as an evidence of alizarin complexon binding different met-
als – Mo (A) as molibdate MoO42− and Ni2+ (B)
O. Woźnicka et al.
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Complexation is further hampered by the fact that fibrils often consist of multiple 
intertwined strands – in such cases the ligand may engage individual strands with-
out disrupting the fibril as a whole. This theory is supported by EM analysis, show-
ing that CR does not uniformly cover the entire fibril, despite an abundance of the 
dye (Fig. 4.4), and that the fibril is unwound in many areas. It should also be noted 
that ribbon-like CR may attach itself to amyloids by means of adhesion.
Immune complexes are another type of object which can be visualized in the 
same manner – this is due to the fact that, by binding their natural ligand, antibodies 
Fig. 4.8 Spectral changes presented as an evidence of alizarincomplexon binding ions of different 
metals – Cu (A) and Co (B). The spectrum change marked by dotted line indicates that Cu2+ com-
plexation reveals the formation of modified complex at the excess of Cu2+ ions added. Molar ratio 
of AC: Cu2+ 1:2
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incur local structural instabilities which render them susceptible to penetration by 
supramolecular dyes, such as CR.
The proposed ligands and the procedure outlined in this work are both prelimi-
nary in scope. The technique can be further optimized by carefully selecting reagents 
and modifying the manner in which metal ions are transported by supramolecular 
ligands.
Fig. 4.9 Islands of ordered 
structures formed within 
the amyloid-like particle 
stained selectively with 
CR/AC/WoO42− complex
Fig. 4.10 Amyloid-like 
particles with ordered 
structures inside stained 
with CR/AC/Pb+2
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Fig. 4.11 Islands of ordered structure within amyloid-like particle stained selectively with (A) 
CR/AC/Pb2+ complex used as the contrast for EM studies. (B and B’) - enlarged fragments, (C) - 
islands of ordered structures seen in amyloid-like particle in polarised light
Fig. 4.12 The ordered 
structures bearing fragment 
outgrowing unstructured 
amyloid particle stained by 
CR/AC/Pb+2. Local burst 
of ordered structures
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Chapter 5
Possible Mechanism of Amyloidogenesis of V 
Domains
Mateusz Banach, Barbara Kalinowska, Leszek Konieczny, 
and Irena Roterman
Abstract This chapter discusses complexation of Congo red by amyloid structures 
comprising immunoglobulin light chains, particularly the so-called Bence-Jones 
(BJ) proteins. According to the presented study, in BJ proteins the V domain is sub-
stantially less stable than the C domain. This conclusion is based on quantitative 
analysis of the protein’s hydrophobic core, made possible by the fuzzy oil drop 
model. Results indicate that the V domain exhibits structural ordering characteristic 
of amyloid aggregates, i.e. linear propagation of local hydrophobicity peaks and 
troughs rather than a monocentric hydrophobic core (typically present in globular 
proteins). On this basis, the authors propose a hypothetical arrangement of V 
domains which leads to formation of an amyloid. Structural similarities between V 
domains in BJ proteins and other types of amyloid aggregates enable the authors to 
study the specific mechanism of Congo red complexation by amyloids.
The proposed Congo red complexation mechanism builds upon the authors’ pre-
vious experience with bioinformatics tools. The subject should be of interest to 
researchers specializing in protein folding studies and misfolding diseases.
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5.1  Characteristics of Immunoglobulin Domains
Complexation of supramolecular Congo red (CR) requires considerable relaxation 
of the target protein’s native form. Immunoglobulin domains are known for their 
structural instabilities (amyloidogenic properties), and also for their ability to 
eagerly bind CR. In line with basic biochemical knowledge, the stability of proteins 
is determined by two factors: disulfide bonds and hydrophobic core.
Immunoglobulin domains are β-sandwiches composed of two distinct fragments, 
referred to as the upper core and the lower core respectively. Each domain includes 
one centrally placed disulfide bond linking both cores. While the stabilizing influ-
ence of this bond allows the domain to persist in its native form, individual domains 
vary greatly with respect to the structure of their hydrophobic cores [1]. This diver-
sity is evidenced by structural analysis based on the fuzzy oil drop (FOD) model. 
FOD is an extension of the “oil drop” hydrophobicity distribution model, which 
introduced a binary distinction between the outer (hydrophilic) and inner (hydro-
phobic) layers [2]. The name of the model alludes to the notion of an oil drop 
immersed in water – the hydrophobic substance attempts to minimize its contact 
surface, becoming spherical in the process. Similarly, the protein folding process 
results in internalization of hydrophobic residues and exposure of hydrophilic resi-
dues on the surface of a globular capsule [3].
As already remarked, the fuzzy oil drop model extends the binary oil drop para-
digm by introducing a continuous gradient of hydrophobicity between the core and 
the surface. This gradient is mathematically expressed by a 3D Gaussian, which 
peaks at the center of the molecule and then gradually decreases, reaching near-zero 
values at a distance of 3σ (where σ is the coefficient of the Gaussian).
In this chapter we will apply the fuzzy oil drop model in the analysis of immu-
noglobulin light chain domains exemplified by Bence-Jones proteins [4].
5.2  Target Proteins
Table 5.1 provides a summary of proteins selected for analysis. They are collec-
tively referred to as Bence-Jones (BJ) proteins [4] and are exclusively of human 
origin. Each protein is a homodimer comprised by two identical IgG light chains.
The sole exception is 2Q1E, where two pairs of V domain dimers have been 
identified in the crystal structure. The reference protein is the Fab fragment of 
human immunoglobulin G (4PUB), consisting of the light chain (L) and the heavy 
chain (H).
The fuzzy oil drop has been applied in the analysis of the following structural 
units: both chains in complex; paired domains – V(L)-V(L) and C(L)-C(L), each 
domain individually and for 4PUB the complexes of domains V(L)–V(H) and C(L)-
C(H). We have also assessed the status of each domain as a structural subunit of the 
complete dimer.
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5.3  The Fuzzy Oil Drop Model
The fuzzy oil drop model has been extensively described in numerous publications 
[3, 12, 13]. The description presented below should therefore be regarded only as a 
brief introduction.
The traditional notion of a “hydrophobic core” refers to a concentration of hydro-
phobic residues at the geometric center of the protein, along with exposure of 
hydrophilic residues on its surface. When dealing with globular proteins, this con-
figuration can be described with a 3D Gaussian, where the origin of the coordinate 
system coincides with the geometric center of the molecule and a separate σ coef-
ficient is defined for each principal axis, delineating an ellipsoid capsule. The mol-
ecule itself should be oriented in such a way as to align its orthogonal dimensions 
(longest diagonals) with axes of the coordinate system. Values of σx, σy and σz are 
calculated as 1/3 of the separation between the origin of the system and the position 
of the most distant atom along each axis. This is schematically depicted in Fig. 5.1.
In accordance with the three-sigma rule, over 99% of the total volume of the 
Gaussian is captured by applying a cutoff distance of 3σ in each principal direction. 
The value of the Gaussian at any point within this ellipsoid capsule is interpreted as 
local theoretical hydrophobicity (also referred to as the “idealized” distribution).
The theoretical hydrophobicity distribution should be confronted with the 
observed distribution, which depends on local interactions between each residue 
and its neighbors. These calculations are based on the positions of the so-called 
effective atoms (averaged-out positions of all atoms comprising a given residue) and 
the intrinsic hydrophobicity of each amino acid. Each effective atom collects inter-
actions with its neighbors, with a cutoff distance of 9 Å.


















































Table 5.1 Proteins selected for analysis
Protein – ID PDB Dimer Chain class References
1B6D L-L KAPPA [5]
1BJM L-L LAMBDA [6]
1DCL L-L LAMBDA [7]




2Q1E L-L-TETRAMER KAPPA [10]
3BJL L-L LAMBDA [6]
4PUB H-L [11]
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Ht j
˜  is the theoretical hydrophobicity density (hence the t designation) at the jth 
point in the protein body. x y z, ,  correspond to the peak of the Gaussian in each of 
the three principal directions, while σx, σy, σz denote the range of arguments for each 
coordinate system axis. These coefficients are selected in such a way that 99% of the 
Gaussian’s integral is confined to a range of x ± 3s . Values of the distribution can 
be assumed to equal 0 beyond this range.
If the molecule is placed inside a capsule whose dimensions are given by 
x y zx y z± ± ±3 3 3s s s, ,  then the values of the corresponding Gaussian represent 
the idealized hydrophobicity density distribution for the target protein. If σx = σy = 
σz, the capsule is perfectly spherical; otherwise it is an ellipsoid. The Gaussian 
yields hydrophobicity density values at arbitrary points in the protein body – for 
example at points which correspond to the placement of effective atoms (one per 
side chain). Ht j˜  is the hydrophobicity density determined for the jth amino acid 
while x, y and z indicate the placement of its corresponding effective atom.
The denominator of 
1
Htsum
˜  expresses the aggregate sum of all values given by
 the Gaussian for each amino acid making up the protein. This enables normalization
of the distribution since        will always be equal to 1.0.Ht j˜
Htj
˜  values reflect the expected hydrophobicity density which should correspond 
to each amino acid in order for the hydrophobic core to match theoretical predic-
tions with perfect accuracy, with all hydrophobic residues internalized and all 
hydrophilic residues exposed on the surface. The closer to the surface the lower the 
expected hydrophobicity density.
The position of each (jth) residue is represented effective atom localized at the 
geometric center of all atoms belonging to side chain of the residue under consider-
ation (including Cα in the case of Gly). Protein encapsulation is presented in 
Fig. 5.1.
On the other hand, the actual distribution of hydrophobicity density observed (O) 
in a protein molecule depends on inter-chain interactions, which, in turn, depend on 
the intrinsic hydrophobicity of each amino acid. Intrinsic hydrophobicity can be 
determined by experimental studies or theoretical reasoning – our work bases on the 
scale published in [12] while the force of hydrophobic interactions has been calcu-
lated using algorithms proposed in [14]. For each amino acid j (or, more accurately, 
for each effective atom) the sum of interactions with its neighbors is computed and 
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N is the number of amino acids in the protein,      expresses the hydrophobicity 
parameter of the i-th residue while rij expresses the distance between two interacting 
residues (jth effective atom and ith effective atom). c expresses the cutoff distance 
for hydrophobic interactions, which is taken as 9.0 Å (following [14]). The Hosum
˜  
coefficient, representing the aggregate sum of all components, is needed to normal-
ize the distribution which, in turn, enables meaningful comparisons between the 
observed and theoretical hydrophobicity density distributions.
Quantitative analysis of the differences between expected (T) and observed (O) 
distributions is enabled by the Kullback-Leibler entropy formula [15]:
 











The value of DKL expresses the distance between the observed (p) and target (p0) 
distributions, the latter of which is given by the 3D Gaussian (T). The observed 
distribution is referred to as O.
Hi
r˜
Fig. 5.1 Protein molecule placed in an ellipsoid capsule (only two dimensions are presented to 
preserve clarity). The adjacent one-dimensional plots present values of the Gaussian along each 
axis and highlight the role of σ coefficients. Color coding expresses the transition between hydro-
philic (blue) and hydrophobic (red) residues. An intermediate layer is present between the core and 
the surface
5 Possible Mechanism of Amyloidogenesis of V Domains
82
For the sake of simplicity, we introduce the following notation:
 
O T O O T
N
i




Since DKL is a measure of entropy its interpretation requires a reference value. In 
order to facilitate meaningful comparisons, we introduce another boundary distribu-
tion (referred to as “unified” or R) which corresponds to a situation where each 
effective atoms represents the same hydrophobicity density (1/N, where N is the 
number of residues in the chain). In this type of distribution hydrophobicity density 
is not concentrated at any point in the protein body.
 
O R O O R
N
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Comparing O|T and O|R tells us whether the given protein (O) more closely 
approximates the theoretical (T) or unified (R) distribution. Proteins for which 
O|T > O|R are regarded as lacking a prominent hydrophobic core. To further sim-








/ /  
Here, RD < 0.5 indicates the presence of a hydrophobic core.
Figure 5.2 presents a graphical representation of RD values, restricted (for sim-
plicity) to a one dimensional form.
DKL (as well as O|T, O|R and RD) may be calculated for specific structural units 
(complex, single molecule, single chain, selected domain). In such cases the bound-
ing ellipsoid is restricted to the selected fragment of the protein. It is also possible 
to determine the status of polypeptide chain fragments within the context of a given 
ellipsoid. This procedure requires prior normalization of Oi, Ti and Ri values belong-
ing to the analyzed fragment.
The procedure described above will be consistently applied in the analysis pre-
sented in this chapter. The status of selected polypeptide chain fragment will be 
studied to evaluate their participation in forming a hydrophobic core. In particular, 
secondary folds which satisfy RD < 0.5 are thought to contribute to the molecule- 
wide hydrophobic core. When the opposite is true (i.e. RD > 0.5), the given frag-
ment can be considered unstable. It appears that fragments which exhibit 
higher-than-expected hydrophobicity may, when exposed on the surface, be engaged 
in protein complexation (forming parts of the interface).
Calculations concerning fragments of the polypeptide chain requires prior nor-
malization of Ti, Oi and Ri values belonging to the selected fragment. The results tell 
us whether the given fragment contributes to the molecule-wide hydrophobic core.
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Fragments can be selected for analysis on the basis of their involvement in par-
ticular secondary structures [1], supersecondary structures [16], interface areas 
[17], intrinsically distorted fragments [18], chameleon fragments [19] or other types 
of structures, depending on the research problem at hand.
A summary of sample proteins, visualizing the varied status of their hydrophobic 
cores, is provided in Fig.  5.3. Titin (Fig.  5.3A) is a protein which includes an 
immunoglobulin- like fold, exhibiting very good agreement between the theoretical 
and the observed hydrophobicity distribution. In this case hydrophobicity is concen-
trated near the center of the protein, with a hydrophilic layer present on the surface, 
optimizing the protein’s contact with water. Such high agreement between T and O 
enables titin to revert to its native conformation in the absence of external forces 
(note that titin is found in muscle tissue and subject to frequent stretching).
The second sample protein, visualized in Fig. 5.3B, is the H chain of the human 
immunoglobulin Fab fragment. In this case major discrepancies between the theo-
retical and observed hydrophobicity distribution are observed (RD = 0.584), indi-
cating that no monocentrichydrophobic core is present and that the H chain as a 
whole is only marginally stable. Further stabilization is provided by two disulfide 
bonds present in the Fab fragment. Notably, immunoglobulin appears to require a 
flexible V domain in order to align itself with the antigen.
The third protein, transthyretin, is a known amyloid precursor (Fig. 5.3C). Major 
differences between the N-terminal and the C-terminal fragments are evident. The 
protein as a whole does not follow the theoretical distribution of hydrophobicity, 
although the N-terminal section is a far better match for the theoretical values than 
its C-terminal counterpart. In such cases, it is informative to compute RD values for 
specific fragments of the chain, revealing the degree of their participation in the 
protein’s hydrophobic core.
The presented work focuses on Bence-Jones complexes formed by IgG light 
chains [4]. Detection of such proteins in urine may indicate multiple myeloma or 
Waldenström’s macroglobulinemia. Large deposits of B-J proteins are also encoun-
tered in kidneys and may cause amyloidogenesis [20].
Fig. 5.2 Graphical representation of fuzzy oil drop model parameters, reduced to a single dimen-
sion. (A) theorized Gaussian distribution (T). (B) actual hydrophobicity distribution in the protein 
under consideration. (C) uniform distribution (R). (D) The RD parameter (equal to 0.656) marked 
on the horizontal axis as a pink dot. According to the fuzzy oil drop model this protein does not 
contain a well-defined hydrophobic core
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Fig. 5.3 Comparison of three proteins: (A) O matches T  - immunoglobulin-like domain; titin; 
RD = 0.326. (B) O diverges from T – domain V chain L; human immunoglobulin Fab fragment; 
RD = 0.584. (C) O partially matches T; however areas of significant discordance are evident – 
transthyretin; RD = 0.562 (entire chain), 0.475 (accordant fragment at 10–57), 0.621 (discordant 
fragment at 51–124). The vertical line marks the boundary between both fragments
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The reference complex is provided by the light/heavy chain dimer corresponding 
to the native form of immunoglobulin (4PUB).
5.4  Structure of Hydrophobic Core in B-J Proteins
The fuzzy oil drop model has been applied to identify the status of immunoglobulin 
domains in proteins referred to as Bence-Jones complexes. This choice of proteins 
is motivated by their specific properties, particularly their ability to quickly transi-
tion into amyloid forms (indicating structural instabilities) and their high affinity for 
supramolecular CR.
The fuzzy oil drop model reveals the status of the complete protein (complex), its 
individual domains as well as fragments of polypeptide chains – the presented anal-
ysis covers the status of the interface area and the N-terminal fragment which has 
been experimentally characterized as highly unstable [21].
5.4.1  Dimers of L-L Chains in Bence-Jones Proteins 
and of L-H Chains in the Fab Fragment
Table 5.2 presents a comparison of RD parameters describing full-chain dimers and 
V/C domains present in the complex. Analysis of results indicates that the full-chain 
dimer does not contain a shared hydrophobic core in the sense of the fuzzy oil drop 
model (with all corresponding RD values in excess of 0.5).
When analyzed as components of the complex, V domains exhibit high RD val-
ues, which suggests that they lack prominent monocentrichydrophobic cores. Two 
exceptions to this rule are 1LIL and 2Q1E. In the latter case, the discrepancy is due 
to altered composition of the V domain tetramer crystals, where each unit cell com-
prises two dimers with two domains per dimer. For this reason, 2Q1E will be fre-
quently seen as an outlier in further analysis.
C domains analyzed in the context of the dimer exhibit good agreement with the 
theoretical hydrophobic core structure.
Interesting properties are revealed for the light/heavy chain complex in the Fab 
IgG fragment, where each domain is discordant in the context of the complex-wide 
hydrophobic core.
5.4.2  V(L)-V(L), C(L)-C(L), V(H)-V(L) and C(H)-C(L) Dimers
Since immunoglobulin chains consist of clearly distinguished paired domains, it is 
interesting to study the status of V(L)-V(L) and C(L)-C(L) dimers. Table 5.3 pro-
vides the corresponding quantitative characterization. In the case of the Fab frag-
ment, we have analyzed its V(L)-V(H) and C(L)-C(H) dimers, which should be 
regarded as a reference.
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Table 5.2 RD values describing individual domains of light chain dimers in Bence-Jones proteins
Protein – ID PDB Dimer Chain/domain V RD Chain/domain C RD
1B6D 0.778 A-V (1-107) 0.541 A-C (108-211) 0.470
B-V (1-107) 0.566 B-C (108-211) 0.417
1BJM 0.718 A-V (2-111) 0.558 A-C (112-212) 0.383
B-V (2-111) 0.590 B-C (112-212) 0.331
1DCL 0.752 A-V (1-111) 0.588 A-C (112-212) 0.344
B-V (1-111) 0.567 B-C (112-212) 0.343
1LIL 0.733 A-V (2-107) 0.473 A-C (108-211) 0.347
B-V (2-107) 0.485 B-C (108-211) 0.336
2OLD 0.734 A-V (2-112) 0.588 A-C (113-213) 0.376
B-V (2-112) 0.591 B-C (113-213) 0.310
2OMB 0.803 A-V (2-112) 0.597 A-C (113-213) 0.420
B-V (2-112) 0.589 B-C (113-213) 0.303
C-V (2-112) 0.602 C-C (113-213) 0.351
D-V (2-112) 0.600 D-C (113-213) 0.347
2OMN 0.750 A-V (2-112) 0.592 A-C (113-213) 0.390
B-V (2-112) 0.581 B-C (113-213) 0.300
2Q1E 0.786 A-V 0.492 A-C 0.492
B-V 0.507 B-C 0.507
C-V 0.489 C-C 0.489
D-V 0.464 D-C 0.464
3BJL 0.712 A-V (2-111) 0.583 A-C (112-212) 0.375
B-V (2-111) 0.586 B-C (112-212) 0.312
4PUB 0.747 H-V (2-122) 0.754 H-C (123-223) 0.663
L-V (1-107) 0.818 L-C (108-212) 0.728
The reference protein (4PUB) is the Fab fragment of human immunoglobulin, composed of light 
(L) and heavy (H) chains
Table 5.3 RD values for V and C domain dimers
Protein
V-V dimer C-C dimer
Complete No P-P P-P Complete No P-P P-P
1B6D 0.752 0.573 0.630 0.538 0.508 0.505
1BJM 0.683 0.648 0.492 0.529 0.492 0.317
1DCL 0.751 0.732 0.505 0.540 0.513 0.291
1LIL 0.695 0.663 0.643 0.502 0.445 0.245
2OLD 0.714 0.697 0.534 0.546 0.525 0.300
2OMB 0.755 0.731 0.745 0.542 0.521 0.535
2OMN 0.750 0.728 0.596 0.532 0.520 0.283
2Q1E 0.753 0.722 0.475
3BJL 0.655 0.630 0.385 0.561 0.528 0.291
4PUB 0.649 0.603 0.450 0.531 0.515 0.373
The “no P-P” columns characterize the status of domains following elimination of residues 
involved in P-P interactions, while the “P-P” columns presents the interface fragments. Values 
listed in boldface represent discordance
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Figure 5.4 presents the theoretical and observed distribution of hydrophobicity in 
1B6D (B-J protein). Of note is the significant deviation corresponding to the V 
domain, with only the C-terminal complex consistent with the theoretical distribu-
tion. Comparison of V domain profiles with their C domain counterparts reveals 
greater stability of the C dimer (at least from the point of view of its hydrophobic 
core structure).
In all listed proteins, full V-V and C-C dimers deviate from the expected mono-
centric distributions of hydrophobicity. Elimination of residues involved in inter- 
domain interactions produces a reduction in RD values, showing that the interface 
zone disrupts the structure of the hydrophobic core in each domain.
On the other hand, when analyzing the distribution of hydrophobicity in the 
interface itself, it turns out that a significant majority of C-C dimers match the theo-
retical distribution, and the same is true for the Fab fragment. Evidently, the distri-
bution of hydrophobicity in interface residues corresponds to FOD predictions 
(except in 1B6D and 2OMB).
In general, the structure of C-C dimers may be interpreted as relatively stable, 
whereas V-V dimers are characterized by low stability.
Fig. 5.4 Hydrophobicity distributions in protein domains: (A) V(L)-V(L), (B) C(L)-C(L). The 
divergence between T and O is greater in V domains than in the C(L)-C(L) dimer
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5.4.3  Individual Domains
This part of the presentation focuses on individual domains regarded as standalone 
structural units. For each domain, a separate 3D Gaussian is plotted and the corre-
sponding RD values calculated. Results are listed in Table 5.4.
If we base our analysis on the textbook definition of a domain (i.e. a distinct 
structural unit which folds on its own), the FOD properties of standalone domains 
should reveal their intrinsic structural stability. Analysis of results presented in 
Table 5.4 suggests significant differences between V and C domains. The former are 
generally discordant (lack hydrophobic cores), while in the latter case a prominent 
hydrophobic core is present for each analyzed B-J protein, with the sole exception 
being 1LIL. Eliminating residues involved in inter-domain interactions bring the 
status of V domains in line with the theoretical model – we may therefore conclude 
that structural instabilities are primarily due to the presence of an inter-domain 
interface. This theory is corroborated by the poor agreement between T and O in the 
interface itself.
Contrasting properties are observed in the V(L) and V(H) domains comprising 
the IgG Fab fragment, with both units conforming to the model. The status of Fab 
V(L) is similar to that of its B-J counterparts.
The observed discrepancies between the status of V and C domains in both 
chains (L and H) provide important clues regarding amyloidogenesis. This phenom-
enon is more frequently observed in B-J proteins, although L-H dimers are not 
immune from it. Notably, amyloidogenesis tends to involve V domains rather than 
C domains [22].
As already remarked, the peculiar status of 2Q1E is due to differences in its crys-
tal structure, with a marked decrease in the quantity of residues involved in inter- 
domain interactions (16 compared to 29–38 in other dimers). Regarding 1LIL, its 
dimerization properties differ from other proteins in the study set due to structural 
differences in the interface zone.
5.5  Role of the N-Terminal Fragment in V Domains
The N-terminal fragment of the light chain V domain has been identified as highly 
unstable on the basis of experimental results [21]. This conclusion is supported by 
molecular dynamics simulations involving B-J proteins.
Eliminating the N-terminal fragment results in a significant decrease in RD val-
ues, proving that the fragment contributes to destabilization of the domain and dis-
rupts its hydrophobic core (Table 5.5).
The disagreement between O and T distribution as observed in N-terminal frag-
ment is visualized in Fig. 5.5. The status of observed hydrophobicity distribution of 
position 5 and fragment 11–14 can be even treated as opposite one versus the 
expected hydrophobicity. RD value for this fragment is equal to 0.604.
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The N-terminal section in the BJ dimer occupies an exposed position, facing the 
environment. This renders it susceptible to structural changes  – it may become 
uncoiled, freeing itself from the influence of the protein (in the sense of the FOD 
model) [21]. Figure 5.6 depicts this situation distinguishing the N-terminal frag-
ment and fragments engaged in interface generation as the region of lower stability 
due to lover engagement in hydrophobic core generation.
According to fuzzy oil drop model – fragments of the polypeptide chain which 
do not contribute to the molecule-wide hydrophobic core are regarded as potentially 
unstable and susceptible to structural changes.
Table 5.5 RD values for 
complete V domains (central 
column) and following 


















Fig. 5.5 The N-terminal fragment – profiles of T, O and H distribution
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5.6  Hypothetical Amyloidogenesis Mechanism Affecting 
the V Domain in B-J Proteins
Applying the fuzzy oil drop model to amyloid structures points to linear propaga-
tion of local hydrophobicity distributions along the long axis of the fibril. The model 
proposed in [24] stipulates that β-structural fragments perpendicular to the fibril’s 
axis exhibit the following properties:
 1. discordant distribution of hydrophobicity vs. theoretical values (there is no 
monocentric core which would ensure formation of a globular protein);
 2. interspersed peaks and troughs of hydrophobicity observed along the unit 
β-structural fragment;
 3. if the amyloid is composed of identical polypeptides, the identical local distribu-
tion is repeated for each unit peptide, with linear propagation of hydrophobicity 
peaks/troughs along the long fibril axis. Similar linear propagation is observed 
for β-structural fragments with varying sequences as long as their overall profiles 
remain similar.
All these conditions can be observed in the 2MVX amyloid [25].
Figure 5.7 summarizes the differences between the observed and theoretical dis-
tribution (the latter of which would ensure the formation of a centralized  hydrophobic 
core). Each fragment (including β-structural ones) is sequentially identical to all 
other folds comprising the amyloid; thus the presented distribution of hydrophobic-
ity can be repeated linearly, along with the corresponding propagation of local peaks 
and troughs (Fig. 5.8).
If linear propagation of local hydrophobicity profiles is taken as a criterion for 
identifying amyloid forms, then the presence of such arrangement should be 
regarded as a seed for further amyloid aggregation. Under certain conditions (e.g. 
shaking) linear propagation effectively “outcompetes” the standard folding process 
which usually produces monocentrichydrophobic cores (see titin profile on 
Fig.  5.3A). The folding process follows the intrinsic hydrophobicity rather than 
generates the common unicentric construction of hydrophobic core. The resulting 
amyloidogenesis may affect either the entire protein (domain), or enable multiple 
proteins to cluster together.
Fig. 5.6 3D visualization 
of the V domain in a B-J 
protein (3BJL), showing 
fragments which diverge 
from the theoretical 
hydrophobicity 
distribution: gray – 
N-terminal fragment; dark 
blue – interface area. VMD 
program was used to draw 
the picture [23]
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Fig. 5.7 Hydrophobicity distribution profiles in fragments as they appear in 2MVX: H – intrinsic 
hydrophobicity corresponding to each amino acid; T – theoretical (expected) hydrophobicity given 
by the FOD model; O – actual (observed) hydrophobicity resulting from inter-residue interactions. 
Red frames mark local peaks, while red circles denote local troughs, both of which represent devia-
tions from the theoretical model. Selected fragments are listed above each chart. The profiles 
shown are identical along the long axis of the amyloidfibril due to identical sequence of peptides 
generating the fibril
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The presented distribution is evident in the V domain of the IgG light chain 
(crystal structure  – 3BJL), and particularly its β-structural fragments at 86–90, 
40–35, 45–50 and 56–51 (note the antiparallel arrangement). Figure 5.9 presents the 
distribution of hydrophobicity in each of these fragments.
As shown in Fig. 5.9, some β-structural fragments deviate from the theoretical 
distribution of hydrophobicity (the RD value for 35–40 equals to 0.676; for 53–60 
fragment equals to 0.593). Those which appear to demonstrate the accordant distri-
bution (fragment 43–50 described by RD  =  0.463; fragment 86–90 by the RD 
value = 0.422) in selected positions represent the hydrophobicity level locally dif-
ferent in respect to the expected one. What is more, the specific local profiles of 
adjacent β-structural fragments enable linear propagation. Figure 5.10 provides a 
3D depiction of this phenomenon. Local minima are bracketed by local peaks, all of 
which propagate linearly and diverge from the theoretical distribution (Fig. 5.10). 
We can also observe a clear correspondence between the observed distribution of 
hydrophobicity and the intrinsic hydrophobicity of each participating amino acid. It 
means no tendency to create the common unicentrichydrophobic core is observed. 
The residues in polypeptide chain accept the conformation following its intrinsic 
hydrophobicity.
The 3D visualization shown on Fig. 5.10 corresponds to the profiles shown in 
Fig. 5.9.
Fig. 5.8 3D presentation 
of linear propagation of 
hydrophobicity peaks (red) 
and troughs (blue). This 
arrangement is markedly 
different from the 
theoretical distribution, 
where hydrophobic 
residues are expected to 
cluster at the center of the 
molecule while hydrophilic 
residues remain exposed 
on its surface (as shown in 
Fig.5.7). VMD program 
was used to draw the 
picture [23]
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Fig. 5.9 Hydrophobicity distributions in the V domain (H  – intrinsic; T  – theoretical; O  – 
observed), plotted for fragments which exhibit linear propagation of local troughs (red circles) and 
peaks (red frames). The order of residues in fragments accordant to anti-parallel orientation of 
β-structural fragments
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5.7  Complexation of Congo Red
According to the experiences with CR binding two models can be distinguished:
 1. Supramolecular CR may serve as a ligand for any protein, as long as the protein 
contains a suitable docking cavity. The ligand micelle wedges itself between two 
adjacent β-structural fragments, as described in [26, 27]. Under these conditions 
the target protein usually retains its monocentrichydrophobic core, along with 
any local deviations associated with natural ligand binding capabilities [28]. The 
supramolecular ligand may occupy the space vacated by a displaced loop, as 
indeed observed in the case of IgG V domain [21]. The potential ligand binding 
site can be recognized using FOD calculation as local hydrophobicity deficiency 
[28]. See also Fig. 2.4.
 2. Supramolecular CR is known for its ability to bind to amyloids. An open ques-
tion concerns the manner in which the dye attaches itself to amyloid aggrega-
tions  – it can be suspected that the mechanism differs from complexation of 
individual proteins. In an amyloid, the putative monocentrichydrophobic core is 
replaced with a distribution of hydrophobicity which reflects the intrinsic proper-
ties of each participating residue. If two or more β-structural fragments exhibit 
similar hydrophobicity profiles, the likelihood of linear aggregation is increased. 
When the entire V domain converts to a form dominated by linear propagation of 
hydrophobicity, a multidomain fibril may emerge, as schematically illustrated in 
Fig. 5.11. It is notable that in such situations the ribbonlike dye micelle comple-
ments the linear form of the amyloid itself (which can also be treated as ribbon- 
like or cylindrical micelle). The orientation of the CR micelle (linear propagation 
Fig. 5.10 3D presentation of the V domain. Red – propagation of hydrophobicity; blue – propaga-
tion of hydrophilicity. The hydrophilic band in the middle of the β-structural fragment, bracketed 
by local peaks, provides a seed for linear propagation. The resulting distribution is a poor match 
for theoretical values (which predict exposure of hydrophilicity on the protein surface). VMD 
program was used to draw the picture [23]
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of local hydrophobicity/hydrophilicity: aromatic rings vs. sulfonic and azo- 
groups) in respect to linear propagation of hydrophobicity peaks (or troughs) in 
amyloid fibrils (as shown in Fig. 5.8) appears to be compatible and able to align 
axially with each other. This observation is not invalidated by the presence of 
axial twists (as discussed in numerous publications), since in this respect the 
same property is shared by the amyloid fibril and the dye micelle making mutual 
adaptation still possible. The liquid crystal form of the CR micelle can align 
itself to a wide variety of linearized hydrophobicity distributions, which explains 
why the dye is capable of forming complexes with various amyloid fibrils – both 
protein-based and peptide-based.
5.8  Hypothetical Amyloidogenesis of V Domains
In summary, we can conclude that – at least according to the fuzzy oil drop model – 
stabilization of BJ dimers is mediated by C domain complexes. In contrast, the V 
domains appear quite unstable. RD values calculated for C-C complexes are only 
slightly above 0.5, while their V-V counterparts are much higher. When structural 
changes are expected in the dimer, the fuzzy oil drop model points to the V domain 
as the preferential location of such changes.
The N-terminal fragment adjacent to the interface zone (Fig. 5.5; Tables 5.4 and 
5.5) is particularly prone to conformational changes resulting from its poor align-
ment with the theoretical hydrophobicity distribution. Such changes may provide 
the seed for amyloid transformation  – although the issue is quite complex and 
requires further study [13, 24].
Fig. 5.11 Similarities  – linear propagation  – in the distribution of local hydrophobicity peaks 
(red) and troughs (blue) in an amyloid plaque (2MVX; a4 β-amyloid) and in the CR micelle. VMD 
program was used to draw the 3D picture [23] and BKChem to draw the CR formula [29]
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Figure 5.12 shows a hypothetical mechanism of multimolecular fibril generation. 
The status of β-structural fragments (as shown in Fig. 5.9) suggests the possible 
propagation of local maxima and local minima of hydrophobicity in contrast to 
expected distribution for these fragments. As it is shown in Fig. 5.12. the approach 
of two units representing similar characteristics is able to make possible propaga-
tion of linear hydrophobicity/hydrophilicity propagation. The red fragments on 
Fig. 5.12 are those shown in Fig. 5.9. According to 3D presentation the fragment 
53–60 (distinguished as pink) is expected to fit its structure to the partner from the 
next unit (domain). Loose N-terminal fragments, devoid of hydrophobic stability 
(as confirmed by molecular dynamics simulations and experimental studies [21, 
26]), may align with one another, creating a new β-interface especially due to its 
localization on the edge of the domain.
The crystal structure of the V-V dimer does not correspond to the actual confor-
mation of these domains in an amyloidfibril. Certain structural changes are expected 
in the N-terminal fragment (Fig. 5.6), but also in the domain as a whole (see [13] for 
a discussion of potential changes expected for fibril formation). In light of this fact, 
it is difficult to speculate about the final structure of the V-V amyloid – although 
conformational rearrangements proposed for transthyretin [13], converting its crys-
tal structure into an amyloid, appear equally possible in the IgG V domain (as seen 
in 3BJL).
The proposed supramolecular CR binding mechanism – one of many possible – 
is superficial in nature and does not require the dye to penetrate the amyloid. This 
explains why CR is able to adhere to amyloids formed by separate domains, as well 
as by identical β-structural fragments comprising a single domain. Due to the spe-
cific type of inter-chain interactions occurring in amyloids, intercalation of the dye 
is unlikely, and while CR may potentially dock in a suitable cavity (as proposed in 
Fig. 5.12 3D presentation of possible interactions between V domains (A and B) different per-
spective. (C) Possible propagation of β-sheet in amyloid form. Arrows indicate possible directions 
of propagation. The same situation occurs in the complementary chain (second IgG light chain – V 
domain). Red – fragments consistent with the hydrophobicity distribution shown in Fig.5.8 and 
therefore capable of linear propagation. The pink fragment (53–60) requires conformational 
changes in order to adapt itself to linear propagation of hydrophobicity minima/maxima in 
β-structural fragments to the next adjacent unit. VMD program was used to draw the picture [23]
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[27] see also Fig. 2.4), this mode of complexation is characteristic of individual 
proteins rather than amyloid fibrils. Finally, the supramolecular CR micelle may 
also wedge itself between parallel amyloid strains, as observed in 2MVX. Additionally 
both forms of supramolecular micelle (CR) as well as amyloid by itself are sensitive 
to external conditions reacting and adopting forms adequate to environmental fac-
tors [30].
The presented mechanism of the V domains transformation into the amyloidfi-
brils can be treated as possible one, obviously assuming that the proposed model of 
amyloidogenesis as the tendency to linear propagation of hydrophobic characteris-
tics is acceptable. The detergent-like interaction of CR with amyloid described in 
this chapter is additionally supported by observation reported in [31].
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Chapter 6
Supramolecular Structures as Carrier  
Systems Enabling the Use of Metal Ions 
in Antibacterial Therapy
J. Natkaniec, Anna Jagusiak, Joanna Rybarska, Tomasz Gosiewski, 
Jolanta Kaszuba-Zwoińska, and Małgorzata Bulanda
Abstract The antimicrobial activity of metal ions, especially silver ions, has been 
known since ancient times. Consequently, finding an accessible, cheap and efficient 
carrier of metal ions remains an important challenge in molecular biology. The 
supramolecular system presented in this chapter consists of a mixture of Congo red 
and Titan yellow molecules forming a supramolecular ligand which is a potent com-
plexing agent of silver ions. Delivery of ions in complex with supramolecular dye is 
advantageous due to the reduced toxicity. In addition, the use of Congo red provides 
selective action and – thanks to increased solubility – facilitates efficient dispersion 
of the carrier dye and excretion from the organism.
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6.1  Introduction
The increasing antibiotic resistance of microorganisms is one of the greatest global 
health problems, as recalled by the World Health Organization [1, 2]. The percent-
age of multi-drug resistant isolates or isolates resistant to commonly used antibiot-
ics is increasing throughout Europe. Actinobacter baumani, Pseudomonas 
aeruginosa and Enterobacteriaceae are included in the top three “critical” patho-
gens which have MDR (Multi-Drug Resistance). They are causing severe, fre-
quently deadly infections and there is a critical need for new drugs to combat these 
pathogens [3–5]. In 2016, most strains  – among Gram negative species 
Enterobacteriacae (such as: Klebsiella pneumoniae or Escherichia coli) that were 
also resistant to the third generation of cephalosporins, fluoroquinolones and ami-
noglycosides  – have been reported in southern and southeastern Europe [6]. 
Methicillin-resistant Staphylococcus aureus (MRSA) is no longer just a hospital 
treatment problem, as in many parts of the world, including Europe, the number of 
MRSA infections (community-associated MRSA, CA-MRSA) is increasing. In 
Europe, eight out of 30 countries have reported having MRSA indexes exceeding 
25% [6]. One of the causes of this problem is the high use of antibiotics, which 
increased significantly in the years 2010–2014  in the European Community, 
although it did not look the same in all countries. For example, in 2014, the number 
of antibiotics administered outside hospital treatments in Greece was more than 
three times higher than in the Netherlands (10.6 DDD (defined daily dose) per 1000 
inhabitants per day in the Netherlands to 34.1 DDD per 1000 inhabitants per day in 
Greece) [7]. Unfortunately, the mere supervising of alarm strains, their registration, 
as well as the control system of antibiotic consumption are insufficient in the fight 
against microbial multi-resistance and searching for alternative means to solve the 
problem becomes necessary.
Among many propositions of solutions we will find e.g.: applying the so-called 
combined therapy, which uses two or more antibiotics administered simultaneously 
or combines the action of two different drugs in one molecule [8]. A promising 
alternative is the combination of chemotherapeutics with heavy metal ions, for 
example: silver, which has been known for its bactericidal properties since ancient 
times [9, 10]. The ideal situation would be to use silver compounds to increase the 
antibacterial effectiveness of commonly known and used antibiotics. However, in 
order for silver ions to be selective, they must be bound to a suitable carrier that 
would allow them to be precisely delivered and, in addition, would allow a more 
effective bacteriostatic/bactericidal effect when coacting with the antibiotic.
Finding an easily accessible, cheap and efficient carrier is one of the most impor-
tant challenges researchers are facing [11, 12]. The carrier system presented here 
consists of a mixed supramolecular system of CR, which binds TY, which is a strong 
complexing agent for silver ions, by means of intercalation. The use of metal ions in 
the form of complexes makes it possible to lower the toxicity threshold. On the 
other hand, using a carrier system provides selectivity of action and, by increased 
solubility, facilitates excretion from the organism.
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6.2  Silver Complexes with TY in the Supramolecular CR 
System
Supramolecularity is the phenomenon of the occurrence of organic compounds in the 
form of multimolecular systems resulting from the association of single molecules 
[13]. The classic example of a supramolecular system is CR (Fig. 6.1A). CR-type 
compounds associate creating elongated ribbon-like structures. Systems produced 
this way demonstrate the ability to bind different guest organic compounds by means 
of intercalation and, consequently, are characterized by various activities resulting 
from the nature of introduced components. Properly selecting the elements for such 
a complex system allows e.g. to increase its polarity and solubility, reduce cell entry 
and facilitate excretion, which further lowers the toxicity of components carried by 
the supramolecular system [14–16]. Supramolecular CR interacts with proteins, 
although it is an atypical ligand, which binds outside the active group of the protein 
[17–20]. There are also reports of bacteria interacting with CR [21–23].
Silver is an example of an antibacterial metal, commonly used locally, mainly as 
metallic silver (nanosilver, colloidal silver). Delivering silver as complexed ions 
using a carrier increases the safety of therapies using this metal. CR, however, has a 
low affinity for binding metals, including silver, hence the search for other com-
pounds that form metal ion complexes with high efficiency. These compounds 
should interact directly with proteins, or indirectly through interaction with CR. 
One of the compounds which partially fulfils these parameters is TY (TY or DY9) 
(Fig. 6.1B) [24, 25]. TY poorly interacts with proteins compared to CR. It however 
creates strong complexes with CR, which can thus be used as a carrier system for 
both TY and its complex with silver ions. The TY molecule is symmetrical and 
planar, although its symmetry is disturbed by the central bond [26]. Similarly to CR, 
TY has a non-polar central benzene ring and polar sulphonic groups located at the 
poles of the molecule. This kind of structure allows for the self-association of indi-
vidual molecules leading to the formation of complex supramolecular systems. 
A triazene bond is located at the centre of the TY molecule. This feature affects the 
Fig. 6.1 Structural formulas: (A) CR; (B) TY; (C) DY 28; (D) TY–silver ions complex
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spatial structure of TY, which is different than in the case of CR. The triazene moi-
ety is involved in the formation of TY complexes with silver ions (Fig. 6.1D), as 
demonstrated by using the TY analogue  – DY 28 which, instead of the triazole 
bond, has a diazo bond and does not form complexes with Ag+ ions (Fig. 6.1C).
The complexation of silver ions by TY was demonstrated by spectral analysis, 
and independently by using sodium dithionite to reduce ternary CR/TY/Ag+ com-
plexes previously subjected to electrophoresis. As a result of reduction CR was 
decomposed and discoloured (because the azo bonds were reduced), the TY stain 
remained unchanged (as the triazene bond was not reduced), while silver appeared 
in the form of dark spots both within the TY/Ag+ complex and the CR/TY/Ag+ 
complex (both migrating towards the anode) as well as in the form of the excess 
migrating towards the cathode [24].
Silver ions are bound by TY in a molar ratio of 1:0.8, as demonstrated by titration 
of TY with silver (Fig. 6.2).
The strength of silver ions – TY interaction was evaluated by spectral analysis of 
the stability of the complexes in the presence of anions present in physiological 
solutions (Br−, PO4−, Cl−, CNS−). Complexing silver ions increases the reactivity 
threshold of silver practically only for -SH groups, which are present on the surface 
of bacteria, because silver reactivity in complexes is reduced. The dissociation con-
stant of the complex was estimated to be approx. 10−13, because the anions with Kd 
values <10−13 did not displace silver from the complex [25].
The viscosity of the TY/Ag+ complex was evaluated using viscometric analysis – 
the analysis of solution sedimentation in time, depending on composition. Viscosity 
Fig. 6.2 Effect of titration of Titan yellow (TY) with silver (Ag+). The optimal molar ratio of 
TY:Ag+ is 1:0.8
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increases with the addition of an increasing amount of silver, hence the conclusion 
that silver cross-links TY molecules (Fig. 6.3B).
These results were confirmed in a diffusion test, which compared the diffusion of 
TY, CR as well as TY/Ag+ and CR/TY/Ag+ complexes in agarose gel over 24 h. The 
Fig. 6.3 (A) Comparison of diffusion rates in agarose gel: TY, CR, TY/Ag+ and CR/TY/Ag+ com-
plexes after 24 h – a significant slowdown of the TY/Ag+ complex diffusion due to increased vis-
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results have shown, that the TY/Ag+ complex practically does not diffuse (diffusion 
zone diameter of 8 mm), and when bound to CR, the diameter of the diffusion zone 
is 18 mm and is close to the free TY (diffusion zone diameter of 20 mm) and free 
CR (diffusion zone diameter of 22 mm). This shows the important role of CR in 
increasing the solubility of the TY/Ag+ complex (Fig. 6.3A).
Since the diffusion zone in the CR/TY/Ag+ complex is 18 mm and is 4 mm smaller 
than the diffusion zone of free CR (which equals 22 mm), we conclude that the TY/
Ag+ complex is bound by CR. TY interacts with CR by intercalation into the ribbon 
structure of CR. The presence of CR in the CR/TY/Ag+ complex reduces the viscos-
ity of the complex, at the same time increasing its solubility. Additionally, the pres-
ence of CR may extend the range of TY activity by binding to certain bacteria 
[21–23]. Both TY and CR are carrying negative charges, yet they manage to interact 
and create stable complexes. This was confirmed in studies using electrophoretic and 
spectrophotometric methods [24, 25]. The results of electrophoresis on agarose gel 
show the formation of CR and TY complexes at an increasing CR to TY molar ratio. 
At two and five times molar excess of TY over CR (CR/TY4 and CR/TY5 samples) 
it was observed that the complex migrating quicker than free CR was formed and no 
excess of CR was observed. At 1:1 molar ratio and 2- and 5-fold excess of CR (CR/
TY3, CR/TY2 and CR/TY1 samples), a smear of free CR was observed. Comparison 
of the migration speed of free TY with all the samples containing complexes (line A) 
indicates the presence of complexes in all five samples migrating at the same rate, as 
opposed to samples containing analogous amounts of free TY migrating at different 
rates (Fig. 6.4). The presence of Ag+ complexed with TY increases the CR binding 
capability, because even at molar ratios of CR to the TY/Ag+ complex equal to 5:1 
and 2:1 (CR/TY/Ag1 and CR/TY/Ag2 samples) there is no free, unbound CR, as it 
was in the case of CR/TY complexes without silver (Fig. 6.5).
A distinct change in the absorption spectrum of TY after binding silver ions was 
observed (Fig. 6.6).
Fig. 6.4 Agarose gel electrophoresis of CR/TY molar ratio: CR/TY1 – 5:1; CR/TY2 – 2:1; CR/
TY3 – 1:1; CR/TY4 – 1:2; CR/TY5 – 1:5; CR (equivalent to molar ratio 1:1); TY-Titan yellow; 
Molar ratio equivalents: TY1 – 5:1; TY2 – 2:1; TY3 – 1:1; TY4 – 1:2; TY5 – 1:5
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Fig. 6.5 Agarose gel electrophoresis of CR/TY/Ag+ molar ratio: CR/TY/Ag1  – 5:1; CR/TY/
Ag2 – 2:1; CR/TY/Ag3 – 1:1; CR/TY/Ag4 – 1:2; CR/TY/Ag5 – 1:5; CR-Congo red (equivalent to 
molar ratio 1:1); TY/Ag+; Molar ratio equivalents: TY/Ag1 – 5:1; TY/Ag2 – 2:1; TY/Ag3 – 1:1; 
TY/Ag4 – 1:2
Fig. 6.6 Absorption spectra: (A) CR and TY; (B) TY and TY/Ag+
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6.3  Antimicrobial and Antifungal Activity of Silver Ion 
Complexes with Titan Yellow (TY/Ag+) and TY/Ag+ 
Complexes with Congo Red (CR/TY/Ag+)
TY is a carrier system for silver ions. In the form of a complex it can affect the effi-
ciency of antibiotics, by acting with them and, at the same time, reducing the toxic-
ity of the used silver.
Free Ag+ ions demonstrate high antimicrobial activity against Gram-positive and 
Gram-negative bacteria, fungi and certain viruses [27]. There are also theories 
regarding the mechanisms which inhibit the actions of silver on bacteria, such as: 
induction of oxygen free radicals or direct destruction of bacterial cell membranes 
by silver ions. Silver ions can interact with bacterial cell walls, bacterial capsule, 
cell membrane proteins, but also penetrate into the cytoplasm [28–30]. Silver ions 
block the activity of respiratory enzymes in bacterial cells, which prevents cellular 
respiration. Ag+ ions have a high affinity to phosphate groups present in nucleic 
acids, thus inhibiting the replication of bacterial DNA [31–33]. Uncomplexed silver 
strongly binds to cell proteins through thiol, amino, carboxyl, imidazole and phos-
phate groups [34]. Silver, however, after complexation with the carrier, can practi-
cally bind only to the -SH groups. It is confirmed by the results presented in 
Table 6.1, which show a similar reactivity of silver-sensitive bacteria towards silver, 
as well as towards Ellman’s reagent, which is specific for binding thiol groups. The 
amino acid found in the wall of bacteria susceptible to the activity of silver is cyste-
ine, with a highly reactive -SH group [35, 36].
Excessive amount of silver introduced to the body accumulates in the tissues and 
can lead to necrosis of some organs, such as the liver. The concentration of silver 
ions over 10 mg/mL may be toxic for the organism [33], and the wide and uncon-
trolled use of silver can lead to developing bacterial resistance to silver, as currently 
is the case of antibiotics. It is therefore justified to search for silver carriers which 
allow its controlled release and also removal from the body [31].
In the nineteenth century the antiseptic properties of silver against microorgan-
isms (Staphylococcus aureus, Streptococcus, Pseudomonas; Escherichia) were 
proven [37]. To date, silver nitrate has been shown to be effective against microor-
ganisms of the genus Neisseria and Pseudomonas. The reduction of toxicity of sil-
ver used in therapy can be achieved by forming organic complexes. Among 
commonly known and used complexes are: silver sulfadiazine salt [38, 39] and sil-
ver complexes with sulfonamide drugs, which act against Gram-negative and Gram- 
positive bacteria [40]. Colloidal silver or immobilized silver nanoparticles e.g. on 
silica carriers, are also used. It seems however, that using supramolecular silver 
carriers is more effective because of the good solubility of the preparation, facili-
tated excretion and prevention of cell entry leading to the reduced toxicity. The 
proposed complex of TY with silver (TY/Ag+) is just this kind of an organometallic 
system with possible therapeutic potential and numerous advantages that indicate a 
chance of its application in medicine. One of the advantages is the use of ionic sil-
ver. The application of this complex limits the accumulation of the metal in the 
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Table 6.1 Screening of TY, CR, Ellman’s Reagent (ER) and the TY/Ag+ for selected strains – 
comparison with the antibiotic appropriate for the given strain: AMC amoxicillin with clavulanic 
acid (30 mg); FEP cefepime (30 mg); NY nystatin (100 IU)
Observation of the size of bacterial inhibition zones (mm) Gray indicates results where the zones 
were greater than zero
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body, due to the facilitation of excretion in the form of a complex. Complexation of 
silver reduces its toxicity and allows for its slow release, which prevents the forma-
tion of therapeutically disadvantageous silver agglomerates [33]. Interaction 
between TY and CR creates a possibility of interaction of the ternary TY/CR/Ag+ 
system with certain proteins, and also leads to the increased solubility of the com-
plex. Another advantage is the specificity expressed by the reactivity of silver ions 
towards thiol groups.
6.3.1  Methodology
In order to evaluate the effect of silver complexed with TY or with the CR/TY sys-
tem we have performed screening tests on gram positive and gram negative bacteria 
and on yeast-like fungi.
The complexes were tested using strains from the collection of the Department 
of Microbiology of the Jagiellonian University Medical College. In the case of 
Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, reference 
strains recommended by EUCAST (European Committee on Antimicrobial 
Susceptibility Testing) were chosen as control strains for susceptibility testing and 
as control strains in quality control. These strains are: Staphylococcus aureussubsp. 
aureus (ATCC® 29213™), Escherichia coli (ATCC® 25922™) – a susceptible strain 
that does not possess any antibioticresistance, Escherichia coli (ATCC® 35218™) – 
a strain producing TEM-1β-lactamase, which causes resistance to all β-lactam 
 antibiotics, Pseudomonas aeruginosa (ATCC® 27853™). Furthermore one strain of 
Staphylococcus aureussubsp. aureus (ATCC® 25923™), which is recommended by 
CLSI (Clinical & Laboratory Standards Institute) for susceptibility testing, was 
chosen.Other reference strains: Staphylococcus epidermidis (ATCC® 700296™), 
Pseudomonas aeruginosa (ATCC® 33348™), Enterococcus faecalis (ATCC® 
2912™), Streptococcus agalactiae (ATCC® BAA-611™), Streptococcus pyogenes 
(ATCC® 700294™), Candida albicans (ATCC® 10231™) were selected according to 
their availability, as were the clinical strains: Pseudomonas aeruginosa (1815), 
Pseudomonas aeruginosa (18168), Pseudomonas aeruginosa (22726), Escherichia 
coli (E1), Escherichia coli (E123), Escherichia coli (M243), Staphylococcus aureus 
(277), Staphylococcus aureus (1934), Staphylococcus aureus (26265).
A diffusion-disk screening method was used to test for antibacterial and antifun-
gal activity by using a filter paper disc impregnated with the tested compound at a 
specific concentration. It has been assumed that the tested compound will behave 
similarly to the antibiotic-impregnated disc in the Kirby-Bauer diffusion-disc 
method, which is used for the determination of drug-susceptibility of microbes. The 
diffusion process is radial, so a concentration gradient is created. The highest con-
centration of the tested antibiotic is at the edge of the disc and decreases with the 
distance. The diameter of the microbial growth inhibition zone is directly propor-
tional to the antibiotic susceptibility, i.e. the greater the growth inhibition zone 
around the disc, the more the microorganism is susceptible to the given antibiotic. 
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Depending on the size of this zone, microbes are defined as: sensitive, medium 
sensitive or resistant, based on the accepted standards (EUCAST 
recommendations).
Ten microlitres of the tested compound were applied onto sterile filter paper 
discs, and then placed on MHA (Mueller-Hinton Agar) media inoculated with bac-
terial suspension or Sabouraud medium inoculated with fungi suspension (optical 
density of the suspensions was 0.5 McFarland). The compound diffused into the 
medium and, if a microbial growth inhibition zone was observed around the disc 
with a diameter at least 1 mm greater than the diameter of the disc impregnated with 
the test compound, it was treated as a positive effect of the tested compound.
First, the control system was tested using free TY without the complexed metal 
and free CR. On the media, inoculated with the suspension of bacteria or fungi 
strains prepared in a standard way, were placed two sterile filter paper discs (Ø, 
diameter = 5 mm) impregnated with 0.9% NaCl (control), the tested compound, i.e.: 
TY (2.9 mM) or CR (2.9 mM) and, additionally, a disc with an antibiotic, selected 
so to have the widest spectrum of antimicrobial activity possible. As for the strains: 
amoxicillin with clavulanic acid (AMC) was used at the concentration of 30 mg for 
S. aureus, E. coli, Enterococcus faecalis,Streptococcus pyogenes,Streptococcus 
agalactiae; a disc with cefepime at the concentration of 30  mg was used for 
Pseudomonas aeruginosa; Nystatin was used at the concentration of 100  IU for 
Candida albicans.
Subsequently, two concentrations of the TY/Ag+ complex were tested (concen-
trations of TY: 2.9 mM and 5.75 mM; Ag+ concentrations respectively: 2.3 mM and 
4.6 mM; molar ratio of TY:Ag+ = 1:0.8). The CR/TY/Ag+ ternary complex was also 
tested (two concentrations of TY and CR: I.  TY: 2.9  mM; CR: 2.9  mM, Ag+: 
2.3 mM; II. TY: 5.75 mM; CR: 5.75 mM, Ag+: 4.6 mM; in both cases the molar ratio 
of TY:Ag+ = 1:0.8; the molar ratio of CR:TY 1:1). Sterile paper discs (Ø = 5 mm) 
were used, impregnated respectively with a filter solution of TY silver complex 
(TY/Ag+), in two tested concentrations or in a solution of CR/TY/Ag+. A disc 
impregnated with 0.9% NaCl was used as control. The discs thus prepared were 
placed on the MHA medium, inoculated with a bacterial suspension and on a 
Sabouraud medium, inoculated with a fungi suspension. Microbial suspensions 
were prepared from reference (Table 6.1) and clinical (Table 6.2) strains and each 
had an optical density of 0.5 McFarland.
The selective activity of Ag+ complexed with TY or with CR/TY was assessed by 
tests, which consisted of comparing the effects of TY/Ag+ and CR/TY/Ag+ and the 
effects of the Ellman reagent (ER). Ellman’s reagent is 5,5′-dithiobis (2- nitrobenzoic 
acid), abbreviated as DTNB – which binds and blocks the thiol groups. The concen-
tration of ER used was 2.9 mM, which corresponds to the molar concentration of 
silver used. The procedure of preparing the microbial suspensions was performed as 
before. On the inoculated plates with the MHA or Sabourand medium, a control 
disc impregnated in 0.9% NaCl, a disc with one of the four aforementioned com-
pounds and a disc with the antibiotic were applied.
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Table 6.2 Results of the screening test of TY, CR, Ellman’s Reagent (ER) and TY/Ag+ for selected 
clinical strains. Shaded cells indicate results with zones above zero
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6.3.2  Results
In both cases, where free compounds were used: TY and CR did not show growth 
inhibition zones either in the test strains tested (Table  6.1) or in clinical strains 
(Table 6.2).
Growth inhibition zones after the application of different concentrations of Ag+ 
complexed with TY were observed in the case of the strains: S. aureus, E. coli, S. 
epidermidis, P. aeruginosa, C. albicans. No growth inhibition zones were observed 
for the strains: E. faecalis, S. agalactiae, S. pyogenes (Tables 6.1 and 6.2). Similar 
results were obtained for CR/TY/Ag+ complexes.
Growth inhibitotion zones after applying ER and TY/Ag+ as well as CR/TY/Ag+ 
were observed for the following reference strains: E. coli ATCC 35218 and S. aureus 
ATCC 25923 (Table 6.1) and in the case of the following clinical strains: E. coli E1; 
E. coli 123; E. coli 243, S. aureus 277; S. aureus 1934 and S. aureus 26265. Based 
on these results it can be assumed that complexed silver inhibits these bacterial 
strains by blocking the thiol groups.
No growth inhibition zones were observed after applying ER, TY/Ag+ and CR/
TY/Ag+ in the case of the following standard strains: E. faecalis ATCC 2912, S. 
agalactiae BAA-611, S. pyogenes ATCC 700294 and in the case of clinical strains: 
E. fecalis E1; E2; S. agalactie 135, 136, 149; S. pyogenes G0, 282, 287.
In the case of reference strainsS. epidermidis ATCC 700296, P. aeruginosa 
ATCC 27853 and ATCC 33348, E. coli ATCC 25922, S. aureus ATCC 29213 and C. 
albicans ATCC 10231, as well as in the case of the clinical strains: P. aeruginosa 
1815, 18168, 22726, and for the higher concentrations of TY/Ag+ for C. tropicalis, 
C. parapsilosis i C. lusitaniae growth inhibition zones were observed after using 
complexed Ag+, whereas such zones were not observed after applying ER. Probably, 
in the case of these strains, silver affects groups other than thiol groups (e.g. amino 
groups).
In experiments using the CR/TY/Ag+ complex, there was a tendency to increase 
the bacterial growth inhibition zone as compared to the experiments, where Ag+ was 
complexed only with TY. This tendency is evident especially when lower concentra-
tion of Ag (2.3 mM) in the CR/TY complex is used. CR significantly reduces the 
viscosity of the TY/Ag+ complex and improves its diffusion. This result, especially 
in conjunction with the tendency of CR to interact with certain bacteria, is the basis 
for recognizing the presented CR/TY system to be an effective silver ion carrier.
6.4  Determination of the Effect of TY/Ag+ and CR/TY/Ag+ 
on Antibiotic Activity on Selected Standard and Clinical 
Bacterial Strains
The increasing resistance of bacteria to standard antibiotics limits the possible use 
of this class of drugs and significantly narrows the therapeutic options. Hence, fur-
ther studies have tested the possibility of using silver in new, yet unresearched TY/
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Ag+ and CR/TY/Ag+ complexes as a possible support for antibiotics (an adjuvant 
system in antibiotic therapy). The effect of analysed silver complexes on antibiotics 
used for selected strains was tested.
Among the strains that gave a positive response of the growth inhibition zone 
after applying the TY/Ag+ complex, three strains of standard reference microorgan-
isms were selected for antibody testing: Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus ATCC 29213 andEscherichia coli ATCC 35218. The study 
was conducted in accordance with the methodology described above. Sterile filter 
paper discs (without or with antibiotics) were impregnated using a selected solu-
tion: (1) disc without antibiotic impregnated with a 0.05 M TRIS-HNO3 solution, 
pH 8.2 (buffer control), (2) antibiotic disc, (3) disc without the antibiotic with a 
solution of the tested compound, and (4) antibiotic disc impregnated with the solu-
tion of test compound. The test compound used was: TY- silver ions complex (TY/
Ag+). Then the discs were applied to plates with MHA media inoculated with bacte-
rial suspension.
The studies showed that compounds combined with silver ions (TY/Ag+) create 
a growth inhibition zone. It was concluded that silver ions complexed with in TY 
does not inhibit the action of any of the tested antibiotics used for the analysed bac-
terial strains. Moreover, when comparing the growth inhibition zones of E. coli and 
S. aureus strains in the presence of antibiotic and the antibiotic combined with the 
test compound (TY/Ag+), an increase of inhibitory action was observed for the 
 combination. This result shows that silver in the presented complex acts as an adju-
vant on the antibiotic used (Table 6.3 and Fig. 6.7).
Reference strains Antibiotic (1) (2) (3) (4)
P. aeruginosaATCC 27853 FEP Ø 26 11 27
S. aureus ATCC 29213 AMC Ø 18 10 28
E. coli ATCC 35218 AMC Ø 13 11 22
Table 6.3 Observation of the size of growth inhibitory zones (mm)
(1) Buffer control (sterile discs with a 0.05 M TRIS-HNO3 solution, pH 8.2), (2) sterile discs with 
antibiotics (3) sterile discs with the TY/Ag+ solution, and (4) sterile discs with antibiotic with the 
solution (TY/Ag+)
Antibiotics used: AMC amoxicillin with clavulanic acid (30 mg); FEP cefepim (30 mg)
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6.5  Cytotoxicity Analysis of the TY/Ag+ Complex
Induction of the apoptosis process is one of the main goals of the designed cancer 
therapies. This is due to the developed mechanisms of cancer cell resistance to pro-
grammed death. Therefore, in the next stage of study, the cytotoxicity of the com-
pounds used was analysed by comparing early apoptosis, late apoptosis and necrosis 
of U937 cells after application of the following concentrations of the TY/Ag+ com-
plexes: 1 μg/mL; 50 μg/mL; 200 μg/mL and 400 μg/mL in a 96 h culture. It was 
shown that 1 μg/mL and 50 μg/mL concentrations of TY do not lead to cytotoxic 
effects in the studied cell line. The concentration of 50 μg/mL of TY/Ag+ results in 
late apoptosis while concentrations of 200 and 400 μg/mL cause necrosis.
Human U937 lymphoid cell line was obtained from the American Cell Culture 
Collection (ATCC, Rockville, MD) and cultured in RPMI 1640 medium (Gibco- 
BRL, USA), supplemented with 10%(v/v) fetal calf serum (Gibco-BRL, USA) heat 
inactivated, L-glutamine 0.2  M and gentamycin 50  μg/mL (Sigma-Aldrich, 
Germany) at 37  °C in a 5% CO2 incubator of 90% humidity. Cell viability was 
monitored by trypan blue exclusion method and counted with a haemocytometer 
(Fuchs-Rosenthal chamber). The experiments were performed on cells in the loga-
rithmic phase of growth under the condition of 98% viability, as assessed by trypan 
blue exclusion. U937 cells were passaged every 4 days. For the experiments U937 
cells were seeded into 96-well (Nunck, Denmark) culture plates and grown at den-
sity of 0.5 × 106 cells/mL in threefold repetition.
24 h after cell passage of U937 the cell line cultured at density 0.5 × 106 cells/
mL, TY, TY/Ag+ or ER reagents suspended in cell culture medium were added to 
the cell cultures.
The final concentration for TY, TY/Ag+ and ER was 50 μg/ml. Cells without any 
reagent treatment constituted a control group.
Fig. 6.7 Diameter of growth inhibition zones of S. aureus ATCC 29213 and E. coli ATCC 35218; 
(1) buffer control (sterile discs impregnated with a sterile 0.05 M TRIS-HNO3 solution, pH 8.2), 
(2) sterile discs with antibiotic (3) sterile discs impregnated with an TY/Ag+ solution and (4) sterile 
discs with antibiotic impregnated with the TY/Ag+ solution
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After 72 h of cell culture duration with the presence of added reagents, U937 
cells were harvested by centrifugation at 280 g for 10 min and used for flow cytom-
etry analysis.
After 96 h lasting U937 cell cultures, cells were harvested, washed twice with 
cold PBS (Sigma-Aldrich, Germany) and resuspended in 1× binding buffer (BD, 
Pharmingen TM, USA) at a concentration of 1× 106 cells/mL. Then, the solution 
(100 μL) was transferred to a 5-mL culture tube, and AnV-APC(AnV-APC, BD, 
Pharmingen TM, USA) and PI (PI, BD, Pharmingen TM, USA) were added, 5 μL 
each. The cells were vortexed gently and incubated in darkness at room temperature 
for 15 min. After adding 1× binding buffer (400 μL), the cells were analyzed on a 
FACS CALIBUR flow cytometer (Becton Dickinson, San Jose, CA) using Cell- 
Quest software to calculate the proportion of ADSCs representing various types. 
Unstained cells, cells stained with AnV-APC alone (for FL-4 fluorescence) and cells 
stained with PI alone (detected in FL-3) were used as controls to set up compensa-
tion and appropriate quadrants. At least 10,000 events were acquired for each 
sample.
The percentage of apoptotic cells was determined with allophycocyanin (APC) 
conjugated annexin V. Propidium iodide was used as a standard flow cytometric 
viability probe to distinguish necrotic cells from viable ones. AnV-APC-positive, 
PI-negative cells (AnV+PI-) were classified as early apoptotic, AnV-APC- and PI- 
positive cells (AnV+PI+) as late apoptotic, and AnV-APC-negative, PI-positive 
cells (AnV-PI+) as necrotic.
Under the experimental conditions, no early apoptotic cells were observed 72 h 
after the addition of reagents (Fig.  6.8). No late apoptosis and necrosis were 
observed in the control cells and the ones treated with the Ellman reagent or free 
TY. Cells treated with TY/Ag+ complex showed late apoptotic effects (Fig. 6.9) with 
a small percentage of necrotic cells (Fig. 6.10). The ability to induce apoptosis in 
tumor cells by the TY/Ag+ complex allows to consider it a promising potential anti- 
tumor system.
Fig. 6.8. Early apoptosis of U937 cells cultivated in vitro for 72 h with three different reagents 
(K - control, ER-Ellmans Reagent 50 μg/mL; T + Tris – Titan yellow 50 μg/mL and T-Ag+ − Titan 
yellow (50 μg/mL) – silver ions complex1:0.8 molar ratio). Data expressed as mean (±SD)
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6.6  Summary
The complexes TY/Ag+ and the ternary complex CR/TY/Ag+ are systems with 
potentially therapeutic effects. The illustrated carrier systems, thanks to their very 
good solubility, reduce the accumulation of metal in the body by facilitating the 
elimination of silver in the form of a complex. Silver complexation reduces toxicity 
Fig. 6.9 Late apoptosis and necrosis of U937 cells cultivated in vitro for 72 h with three different 
reagents (K – control; ER-Ellmans Reagent; T + Tris – Titan yellow and T-Ag+ − Titan yellow- 
silver ions complex). Data is expressed as mean (±SD)
Fig. 6.10 Necrosis of U937 cells cultivated in vitro for 72 h with three different reagents (K – 
control; ER-Ellmans Reagent; T + Tris – Titan yellow and T-Ag+ − Titan yellow-silver ions com-
plex); Data is expressed as mean (±SD)
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and allows to target its action mainly at interactions with thiol groups. Due to the 
interaction between TY and CR, the TY/CR/Ag+ system can additionally interact 
with different bacteria. Supramolecular CR protects against cell entry and reduce 
toxicity of silver ions, while increasing the selectivity of action. Thanks to these 
features the presented system can be more easily excreted from the body. No toxic-
ity of free TY has been found, however it can induce apoptosis following the com-
plexation of silver ions. Studies conducted on bacterial and fungal strains show that 
the complex exhibits antimicrobial activity. This is especially valuable in case of 
resistant bacterial strains that exhibit a significant degree of insensitivity to com-
monly used antibiotics; using the tested complex increases the extent of action of 
these antibiotics, consequently allowing them to be used again in the treatment of 
resistant microorganisms. The obtained results provide the basis for further research 
on the use of the presented organometallic complex in medicine as an antibacterial 
agent.
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Chapter 7
Congo Red Interactions with Single-Walled 
Carbon Nanotubes
Anna Jagusiak, Barbara Piekarska, Katarzyna Chłopaś, 
and Elżbieta Bielańska
Abstract A new method of dispersion of single-wall carbon nanotubes (SWNT) in 
aqueous solution using supramolecular compounds is proposed in this chapter. The 
described system consists of SWNT overlaid by Congo red. SWNT are formed 
from a rolled layer of graphene, providing a large surface area for binding com-
pounds with planar, aromatic structures (including drugs). Congo red is able to 
associate with proteins in the form of supramolecular, ribbon-like structures, and 
may bind various drugs by intercalation.
The study reveals strong interactions between Congo red and the surface of 
SWNT. The authors’ aim was to explain the mechanism driving this interaction. 
Spectral analysis of the SWNT-CR complex, effects of sonication on CR binding, 
microscopic imaging and molecular modelling analyses are all discussed. Results 
indicate that binding of supramolecular Congo red to the surface of nanotubes is 
based on face-to-face stacking. Having attached itself to the surface of a nanotube, 
a dye molecule may attract other similarly oriented molecules, giving rise to a pro-
truding supramolecular appendage. This explains the high affinity of CR for nano-
tubes and the resulting system’s capability to bind drugs.
Analysis of complexes formed by SWNT-CR with the model drug (DOX) and 
with other planar compounds (EB, TY) indicates that it may be possible to construct 
complexes capable of binding multiple compounds simultaneously.
Keywords Single-walled carbon nanotubes • Supramolecular compounds • Bis- 
azo dye • Congo red • Chemical container • Drug delivery system • Shortenng of 
carbon nanotubes • Pi-pi stacking • Face-to-face stacking
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7.1  Methods of Dispersing Carbon Nanotubes – The Search 
for Optimal Dispersion Methods
Carbon nanotubes (CNT) are used in electronics [1], composite materials research 
[2, 3], catalysis [4], textiles [5] and many other areas. A particularly interesting is 
their use in the field of biomedicine: in biosensors [6, 7], medical diagnostics [8, 9], 
transplantology [10, 11], tissue engineering [12] or in pharmacology – including the 
field of targeted therapies [13–16].
In studies on the use of CNT in biomedicine it is necessary to obtain their sus-
pension in water media. CNT are most often found not in the form of single fibres, 
but in the form of bundles stabilized by van der Waals interactions and it is very 
difficult to evenly distribute them in the liquid phase. The purpose of research is 
thus to find the compounds that provide effective dispersion of carbon nanotubes 
and simultaneously bind other compounds, including some drugs. Numerous reports 
concern both covalent or non-covalent modifications of CNT [17].
The covalent modification based on the introduction of functional groups into the 
graphene surface of carbon nanotubes is an effective way to increase CNT disper-
sion. This may, however, lead to changes in the physicochemical properties of CNT 
and create defects in their structure [18–20].
Non-covalent modification is considered a less invasive method. Because of the 
fact, that there is no heating or acidic environment involved, virtually no damage is 
done to the structure of nanotubes [8, 21]. Among non-covalent CNT modifications 
one can distinguish: interactions with amphiphilic molecules  – surfactants (e.g. 
SDS  – sodium dodecyl sulphate, SDBS  – sodium dodecylbenzenesulphonate, 
CTAB  – cetyltrimethylammonium bromide, DDAB  – dimethyldioctadecyl- 
ammonium bromide, Triton, Pluronic [22]). The most effective interactions between 
CNTs and surfactants were observed for surfactants containing a benzene ring in the 
structure (e.g. SDBS), due to the presence of strong pi-pi stacking interactions 
between the phenyl ring and the graphene nanotube surface [23].
Other compounds used for the noncovalent functionalization and dispersing of 
CNT include: ionic liquids (ILs) – which form bucky gels, polymers – especially 
those with aromatic rings in their structure [24], other compounds with an aromatic 
ring [25] (for example ammonium salts containing pyrene rings [26]) and or deoxy-
cholic acid sodium salts [27].
7.2  The Interaction of Congo Red with Carbon Nanotubes
CR, a bis-azo dye, similarly to the carbon nanotube dispersing compounds men-
tioned above, has aromatic rings in its structure. It is therefore possible to form a 
non-covalent pi-pi interaction between CR molecules and the graphene surface of 
carbon nanotubes. Reports can be found in literature on the interaction of CR with 
carbon nanotubes [28–31] and the surface of graphene oxide [32, 33].
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Hu C. et al. [28] describe a complex of single-walled carbon nanotubes (SWNT) 
with CR (SWNT-CR), with water solubility of up to 3.5  mg/mL.  The described 
complex was formed by prolonged grinding of SWNT and CR in the agate mortar, 
followed by drying. In this case CR probably interacts with the surface of nanotubes 
as single molecules bound to the nanotube surface via pi-pi interactions. The 
described method enables nanotubes dispersion, however the results may not be 
reproducible and the CR binding effectiveness is relatively low.
In another paper [31] authors point to the possibility of using CNT for adsorbing 
dyes from aqueous solutions – in post-production wastes containing textile dyes. 
CR was used as a model compound in these studies and the results show an effective 
binding of CR by carbon nanotubes (with a maximum adsorption of 500 mg/g).
The SWNT dispersion method that was used in our studies is based on the soni-
cation of SWNT with CR solution and is much simpler and reproducible than the 
above described method [34]. It leads to the formation of complexes between gra-
phene surfaces of carbon nanotubes and supramolecular ribbon-like structures cre-
ated by CR molecules. An attempt was made to explain the mechanism of interaction 
between the ribbon-like supramolecular compounds like CR and the single-walled 
carbon nanotubes. The results indicate a very efficient binding of CR by SWNT (up 
to 35 mg CR per 1 mg of SWNT) (Fig. 7.1).
In contrast to the method proposed by Hu et al. the samples are not dried, which 
allows for efficient binding of CR – in the form of large supramolecular structures – 
to the SWNT surface. A model of SWNT-CR complex has been proposed based on 
a “face to face” interaction between CR and the carbon nanotube surface. In this 
model, the SWNT play a role of a scaffolding to the surface of which CR molecules 
are bound in the form of supramolecular, ribbon-like structures that protrude from 
the surface of the carbon nanotube. The nanotube-CR interaction involves the pi-pi 
stacking between the benzene rings (Fig.  7.2), as in the case of aforementioned 
surfactants.
The supramolecular character of CR bound to the carbon nanotube surface is 
indicated by the results obtained during the analysis of SWNT-CR complexes 
Fig. 7.1 Binding of an increasing amount of CR by 1 mg of SWNT. (1,2,3,4 – samples)
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formed in solutions of various ionic strengths. The properties of CR as a supramo-
lecular system depend on the ionic strength of the solution [35]. If the ionic strength 
is low, then the ability of CR to form a supramolecular structure is also low, as a 
result of the lack of shielding of the negatively charged sulphonic groups by Na+ 
ions. In contrast, at high salt concentration the supramolecular structure is  stabilized. 
In order to explain if single CR molecules are involved in the SWNT-CR interaction 
or whether the supramolecular structures are required, an analysis of the SWNT-CR 
interaction in solutions of various ionic strengths was performed. All samples were 
prepared in the 0.05 M Tris/HCl pH7.4 buffer. The significant differences in CR 
binding between samples to which 0.145 M NaCl was added and the NaCl-free 
samples were observed (Fig. 7.3).
Fig. 7.2 Model of interaction between single CR molecule (left) and supramolecular CR (right) 
with the SWNT surface (based on calculations presented in [30])
Fig. 7.3 Binding of CR to carbon nanotubes in solutions of different ionic strength. 0.05 M Tris/
HCl buffer pH7.4 without NaCl or with 0.145 M NaCl. The total amount of CR added to the 
sample was taken as 100%
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Additional information concerning the mechanism of CR- nanotube interaction 
is provided by the birefringence of CR-nanotube complexes observed using polar-
ized light microscopy. This phenomenon, which is typical for the amyloid contain-
ing preparations stained with CR, proves that the CR molecules bound to the fibres 
are ordered [36]. The presence of “apple-green” birefringence in histopathological 
samples is a diagnostic criterion for amyloidosis. In the case of the SWNT-CR com-
plexes the birefringence also demonstrates the ordering of CR molecules bound to 
the carbon nanotube surface (Fig. 7.4) and supports the supramolecular, ribbon-like 
character of CR interacting with the carbon nanotube.
Samples containing carbon nanotubes sonicated with highly concentrated CR 
(above 5 mg/mL), presented gel-like properties. CR in these samples was bound to 
SWNT strongly enough not to be removed during filtration through the 
PTFEmembrane (non-bonded CR can pass freely through this membrane) 
(Fig. 7.5A). SWNT-CR complexes in these samples slowly sedimented at the bot-
tom of the test tube but could be easily dispersed even by gentle mixing (Fig. 7.5C). 
The formation of such big, sedimenting complexes can be explained by the presence 
of CR ribbons, which protrude from the surface of nanotubes and cross-link them to 
form stable gels, as in the case of bucky gels resulting from the interaction between 
CNT and ionic liquids (room-temperature ionic liquids, RILs) [24, 37]. In the case 
of solutions containing a lower concentration of CR the resulting solution is clearer, 
but also tends to separate over a longer period of time (Fig. 7.5B).
Spectral analyses have shown changes in the CR spectrum after binding to 
SWNT, demonstrating the interaction between CR and carbon nanotubes (Fig. 7.6). 
This effect is related to the change in the electron structure of the CR molecule after 
binding to carbon nanotubes and is explained by the transition of the CR molecule 
to the quinoid form [34, 38]. A similar phenomenon is described in the case of bind-
ing CR to the surface of graphene oxide [32]. According to the mechanism of the 
interaction between CR and SWNT described in our paper, not all molecules in the 
CRribbon-like structure adhere directly to the surface of the nanotube, while the 
Fig. 7.4 Birefringence of 
the CR bound on SWNT 
(polarized light 
microscopy)
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observed spectral effect  – the shift of the absorbance maximum from 490 to 
510 nm – suggests that all CR molecules (not only those that directly adhere to the 
nanotube surface) participate in the transfer of electrons (and switch to the quinoid 
form) [34].
The SWNT-CR complexes were studied using a variety of microscopic tech-
niques. All analyses have shown that CR binding to the surface of the carbon nano-
Fig. 7.5 (A) SWNT-CR complexes  – filtration on PTFEmembrane; (B) SWNT-CR complex 
obtained from 1 mg of SWNT and 2 mg CR, after filtration, suspended in 1 mL of the buffer; (C) 
SWNT-CR complex obtained from 1 mg of SWNT and 5 mg CR, after filtration, suspended in 
1 mL of the buffer; the dashed line indicates the sedimentation of the gel-like complex
Fig. 7.6 Absorption spectra of free CR and CR complexed with SWNT – maximum of the absor-
bance shifts from 490 to 530 nm
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tubes significantly increased their diameter. Depending on the amount of CR added 
per portion of single-walled carbon nanotubes more or less uniformly loaded nano-
tubes were obtained [34]. The TEM, SEM and AFM images of the SWNT-CR com-
plexes confirm that the interaction between CR and carbon nanotube surface is 
based on the “face to face” stacking. A comparison of transmission microscopy 
images of a free carbon nanotube (Fig. 7.7A) and a CR-loaded nanotube (Fig. 7.7B) 
shows a sixfold increase in nanotube diameter after CR binding. The image shows 
that addition of highly concentrated CR (10 mg/mL) leads to an uniform covering 
of the carbon nanotube with CR. This can be interpreted as a large number of short, 
“face to face” bound CR “ribbons”, attached side by side to the carbon nanotube.
The presence of supramolecular CR ribbons that protrude from the surface of 
carbon nanotubes was confirmed by the results obtained using the ternary complex, 
composed of CR, Titan yellow (TY) and silver ions (CR/TY/Ag) (see Chap. 6). 
Titan Yellow-silver ion complex (TY/Ag) intercalates between CR molecules within 
a supramolecular ribbon. This system was developed because CR molecules do not 
complex metal ions and thus cannot be directly used for contrasting in TEM images 
[39, 40]. Thanks to the use of silvercontrast, the binding sites of the ternary complex 
have been made visible. EDS (energy dispersive spectroscopy) analysis of chemical 
composition, indicated the presence of silver and sulphur in these sites, which 
 confirms the presence of both CR and TY/Ag. Electronically dense silver ions are 
visible primarily in places of higher CR/TY loading. Contrasting with silver ions 
also allowed to confirm the mechanism of supramolecular CR ribbons interaction 
with carbon nanotubes – silver is not directly attached to the carbon nanotube sur-
face, but is bound to the dye that forms a sheath around the nanotube (Fig. 7.8).
Fig. 7.7 TEM micrographs of (A) a single SWNT, without CR; (B) a single SWNT functionalized 
with CR (obtained from 1 mg of SWNT and 10 mg CR, after filtration, suspended in 1 mL of the 
buffer) – CR layers evenly distributed at the surface of a carbon nanotube are visible (dark lines 
indicate the thickness of CR layer)
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The images obtained by scanningelectron microscopy (Fig.  7.9) and atomic 
force microscopy [34] indicate an increase in carbon nanotube diameter after CR 
binding to its surface. Unevenly distribution of dye on nanotubes is seen on 
Fig. 7.9B.
The SWNT-CR complexes were also analysed by molecular modelling, which 
has shown various possibilities of nanotube-CR interaction depending on nanotube 
diameter [30]. In the case of narrow nanotubes, CR partially retains the supramo-
lecular ribbon structure, adhering to the outer nanotube surface, while some of the 
molecules are adsorbed individually on the surface (as shown in Fig. 7.2). In the 
case of wider nanotubes, individual CR molecules adsorb to the nanotube surface 
Fig. 7.8 Complexes of SWNT-CR contrasted by intercalated Titan Yellow-silver ion complexes 
(obtained from 1 mg of SWNT and 5 mg CR/TY/Ag (1:1:0.8 molar ratio), after removal of dyes 
and Ag excess by filtration). The EDS analysis indicates the presence of CR-TY-Ag complexes in 
highly loaded places (indicated by arrows)
Fig. 7.9 SEM images of (A) SWNT and (B) SWNT-CR complex (obtained from 1 mg of SWNT 
and 5 mg CR, after filtration)
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and supramolecular ribbon-like structure of CR is lost. The geometry of the wide 
nanotube increases the contact surface between CR molecule and the nanotube 
which allows to ascribe the dominant role in the creation of the system’s equilib-
rium structure to the pi-pi stacking. Nanotubes of smaller diameter have a smaller 
side wall area that is characterized by a greater curvature. For this reason, partial 
preservation of the supramolecular ribbon structure of CR is preferable. The molec-
ular modelling results show a tendency for CR to group into ribbons, while simulta-
neously leaving a portion of the nanotube surface exposed, which was also observed 
in microscopic images. These results were also confirmed by analysis of the radial 
distribution functions (rdf) between CR and SWNT [30].
7.3  The Incorporation of Other Compounds by SWNT-CR 
Complexes – Examples of Possible Biomedical Use
A particularly interesting feature of carbon nanotube-CR complex is its ability to 
bind other molecules. CNT, as hollow structures, are excellent high volume light-
weight containers, in which other molecules can be enclosed while their large sur-
face allows for efficient adsorption of many compounds. CR (and similar 
compounds) that create ribbon-like supramolecular structures can bind numerous 
polyaromatic planar molecules that intercalate into supramolecular CR ribbon. 
Compounds that can be bound this way include e.g. antineoplastic drug doxorubi-
cin, Titan yellow, rhodamine B. The combination SWNT and CR creates a “chemi-
cal container” characterized by significantly increased capacity and the ability to 
bind different molecules simultaneously. It could be used as a drug carrier, which 
limits the drug’s toxicity and allows for the targeted delivery [41].
An interesting phenomenon of breaking carbon nanotubes resulting from the 
interaction with mixed supramolecular systems was observed. Mixed supramolecu-
lar systems (CR/EB and CR-DOX) interact with carbon nanotubes causing them to 
stiffen and break (Fig. 7.10). Dispersion of nanotubes by CR is not accompanied by 
their shortening. Similar dye – EB shows much lower nanotube dispersing capabil-
Fig. 7.10 Carbon nanotubes shortened after interaction with the mixed supramolecular complexes 
of CR/EB
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ity and does not interact with their surface [42]. The effect of nanotube breaking can 
be explained by the mechanical weakening of the nanotube in the area where a large 
mixed supramolecular system is attached. This phenomenon can also be explained 
by changes in the electron structure of the nanotube and the supramolecular system 
bound to it.
The dispersion of carbon nanotubes based on their interaction with CR is simple, 
efficient and reproducible. Supramolecular systems (both pure CR and mixed) allow 
not only to disperse carbon nanotubes, but can also bind other compounds through 
intercalation. As carriers of different compounds (e.g. fluorescent dyes, drugs, metal 
ions), these complexes present an interesting alternative to the currently used sys-
tems. They can be used in diagnostics as well as targeted delivery systems for drugs 
or metal ions.
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